When One Diagnosis Follows You Everywhere: Electronic health records provide essential continuity of care, but previous diagnostic impressions may sometimes influence subsequent evaluations. An independent second opinion can offer a fresh opportunity to reconsider the history, objective findings, and diagnostic possibilities. Quick Look A second opinion is not necessarily about finding a doctor who disagrees with the first one. Frequently, another physician confirms the original diagnosis—and that confirmation can itself be valuable. But there is another reason to consider a second opinion: Sometimes a fresh set of eyes sees something differently. Modern electronic health records (EHRs) allow physicians throughout a healthcare system to see previous diagnoses, consultations, laboratory results, imaging studies, medications, and clinical notes. This continuity has enormous benefits. There is, however, a potential unintended consequence. Once an initial diagnostic impression enters the medical record, subsequent clinicians may encounter that conclusion before they have independently considered the case. Under some circumstances, this may contribute to what patient-safety researchers call diagnostic momentum. When the original diagnosis is correct, continuity can improve efficiency and reinforce appropriate care. When the diagnosis is incomplete or incorrect, however, an earlier assumption may potentially influence the physicians who evaluate the patient afterward. That is one reason an independent second opinion can sometimes be valuable. Imagine This Scenario You develop persistent abdominal pain and go to the emergency department. After an initial evaluation, the emergency physician believes your symptoms may be caused by gastritis. That reasonable working diagnosis is entered into your medical record. You are admitted to the hospital. The hospital physician sees the emergency department evaluation, including the impression of gastritis. A consultant subsequently reads the hospital physician's note. Another consultant later reads both. Everyone appropriately reviews your laboratory studies, imaging, medications, and previous evaluations. Several physicians have now evaluated you. But there is an interesting question: How many approached the problem without first knowing what the physician before them thought? Perhaps every physician reconsidered the diagnosis independently. Perhaps the previous diagnosis influenced the direction of some of those evaluations. Usually, we cannot know. This distinction is important because seeing another physician is not necessarily the same thing as receiving an independent diagnostic opinion. The Enormous Benefit of the Electronic Health Record Electronic health records have transformed medicine. A physician evaluating you today may immediately have access to years of laboratory studies, imaging, medications, allergies, hospitalizations, consultations, procedures, and diagnoses. This can prevent unnecessary duplication, reveal important patterns, and provide information that might otherwise be unavailable. In an emergency, access to this information can be particularly valuable. The EHR is not the problem. The more subtle question is what happens when previous interpretations travel alongside the objective information. A sodium level of 128 mEq/L is an observation. A CT scan contains objective images that another radiologist can review. A pathology slide can sometimes be examined again by another pathologist. But a statement such as “The patient's symptoms are probably caused by gastritis” is different. It is an interpretation. Once an interpretation appears repeatedly throughout the medical record, it can begin to look increasingly established—even when it originally began as a reasonable but tentative working diagnosis. What Is Diagnostic Momentum? Figure 1. How Diagnostic Momentum Can Develop: An initial working diagnosis may gain influence as it is documented in the electronic health record and encountered by subsequent clinicians. Periodically asking whether the diagnosis still fits the symptoms and objective evidence can help counter anchoring, confirmation bias, and premature diagnostic closure. Patient-safety researchers use the term diagnostic momentum to describe the tendency for an existing diagnostic label to gain influence as it passes from one clinician to another. Closely related cognitive processes include anchoring bias, confirmation bias, and premature closure. Anchoring occurs when an early piece of information receives disproportionate weight. Confirmation bias can occur when subsequent information is preferentially interpreted in ways that support an existing hypothesis. Premature closure occurs when the diagnostic process ends before reasonable alternatives have been adequately considered. These are not necessarily signs of poor medical care or incompetence. They are characteristics of human reasoning. Good clinicians recognize these vulnerabilities and deliberately attempt to counter them. The Agency for Healthcare Research and Quality has specifically discussed diagnostic momentum, anchoring, and early closure as potential contributors to diagnostic error during transitions of care, including the transition between an emergency department and the inpatient hospital team.¹ The Problem List Can Become the Patient's Identity There is another feature of the electronic health record worth considering: the problem list. The problem list is intended to provide clinicians with a concise summary of a patient's important medical conditions. When accurate and regularly updated, it is extremely useful. But problem lists are not perfect. Diagnoses can occasionally remain on them after the original problem has resolved or after later information has changed the clinical picture. A large study involving more than 890,000 patient visits demonstrated that some short-term diagnoses remained on problem lists far beyond their expected clinical duration. For example, acute pharyngitis remained for a median of 343 days and urinary tract infection for 443 days.² This illustrates an important distinction: Being listed in the medical record does not necessarily mean that a diagnosis has recently been independently reconfirmed. Imagine that a patient develops fatigue, muscle pain, and difficulty concentrating. During an early evaluation, one clinician enters a particular diagnosis into the problem list. The diagnosis may have been entirely reasonable at the time. But suppose subsequent findings begin pointing in another direction. If the original diagnosis remains prominently displayed, every new clinician may encounter that label before hearing the patient's story. Over time, the patient can subtly become identified by the diagnosis: “This is a patient with X.” That change in language may also change the starting point of clinical reasoning. Instead of asking, “What is causing this patient's symptoms?” the question can potentially become, “How do these symptoms relate to the diagnosis this patient already has?” Those questions sound similar. They are not quite the same. A Diagnosis Can Outlive the Evidence That Created It Figure 2. A Diagnosis Can Outlive the Evidence: Electronic health record problem lists provide valuable continuity of care, but diagnoses may sometimes remain after a condition has resolved, require reconsideration, or be missing altogether. Regular review helps distinguish confirmed, working, resolved, and uncertain diagnoses and supports more accurate clinical decision-making. Medical diagnoses do not all carry the same degree of certainty. Some are established through highly specific objective evidence. Others appropriately begin as working diagnoses—the best explanation available given the information available at that particular moment. Problems can arise when that distinction becomes blurred. A provisional diagnosis entered during an emergency visit may subsequently appear in the hospital record, specialist consultation, outpatient note, and problem list. Repetition does not necessarily make the diagnosis more certain. This does not mean clinicians automatically accept everything appearing in a medical record. Physicians routinely question, reconcile, update, and remove diagnoses. It simply means that a diagnosis can sometimes persist longer than the evidence supporting it. When the First Diagnosis Is Correct There is an important counterpoint. Patients seeking another opinion should not assume that the second physician will—or should—overturn the first physician's diagnosis. Many second opinions confirm the original assessment. That is valuable. If another qualified physician reviews the evidence and reaches the same conclusion, confidence in the diagnosis may increase. The second physician may also agree with the diagnosis while recommending different testing, treatment, or follow-up. A second opinion should therefore not be viewed as an attempt to prove that the first doctor was wrong. The objective is better information. When the First Diagnosis Is Wrong—or Simply Incomplete Now consider the opposite possibility. Suppose the original diagnosis was entirely reasonable based upon the information available at the time—but incomplete or incorrect. That diagnosis enters the chart. The next physician sees it. Then another physician sees it. As the diagnosis is repeated in subsequent documentation, an interesting transformation can potentially occur: A diagnostic hypothesis can gradually begin to resemble an established fact. That does not mean subsequent physicians blindly accepted it. Nor does it mean this happens routinely. It simply means that previous diagnostic information can influence the environment in which subsequent clinical reasoning takes place. This is precisely where a fresh perspective may occasionally be useful. Clinical Pearl The value of a second opinion is not necessarily disagreement. It is independent thought. The second physician may arrive at exactly the same conclusion as the first. That can be reassuring. But when the diagnosis is uncertain, symptoms do not fit, treatment is failing, or the consequences of a decision are substantial, another qualified physician reconsidering the evidence may provide an additional layer of diagnostic safety. What Does the Research Tell Us? Research on second opinions needs to be interpreted carefully. A systematic review published in Mayo Clinic Proceedings found that second opinions generally confirmed the original diagnosis or treatment, but major changes in diagnosis, treatment, or prognosis occurred in 10% to 62% of cases across the studies reviewed. The investigators emphasized substantial differences among studies and noted that follow-up often could not establish which opinion ultimately proved correct.³ A subsequent systematic review similarly found that many second opinions confirmed the original diagnosis or treatment, while potentially important discrepancies occurred in a subset of cases.⁴ One particularly large study examined 6,791 patient-initiated second opinions across multiple specialties. The second evaluation resulted in recommended changes in diagnosis alone (14.8%), treatment alone (37.4%), and both diagnosis and treatment (10.6%). The investigators appropriately cautioned that these differences do not establish that the first physician was wrong or that the second opinion necessarily improved clinical outcomes.⁵ A changed diagnosis is not automatically a corrected diagnosis. Different physicians may reasonably interpret incomplete information differently. Additional information may also become available between evaluations. The research nevertheless demonstrates something important: Another thoughtful review of a medical problem can sometimes produce clinically meaningful new information. Is an Outside Second Opinion Truly Independent? Figure 3. Making a Second Opinion More Independent: A useful second opinion begins with the patient’s complete story, examination, and objective findings, followed by a broad differential diagnosis and comparison with previous records. The goal is not necessarily to reach a different diagnosis, but to provide another opportunity for independent clinical reasoning. Changing hospitals or medical groups does not necessarily mean that the new physician will be unaware of your previous diagnosis. Healthcare systems may exchange records. Physicians may use compatible EHR platforms. Referral documents may prominently display previous diagnoses. Patients themselves appropriately bring records from previous evaluations. Most of the time, having this information available is beneficial. The goal should not be to prevent the second physician from reviewing previous medical records. Instead, there may occasionally be value in considering when previous diagnostic conclusions enter the reasoning process. The Sequence May Matter When medically appropriate, a patient seeking an independent second opinion might reasonably ask: “Would you be willing to hear my history and review the objective findings before focusing on the previous diagnostic conclusions?” That is very different from withholding medical information. Medications, allergies, previous procedures, laboratory results, imaging, pathology, and other medically important information should be available to the consulting physician. The objective is not to test the doctor. It is to provide an opportunity, when practical, for another physician to construct the case before comparing that reasoning with previous conclusions. The prior records still matter. But the sequence in which information is considered may sometimes matter as well. When Should You Consider a Second Opinion? Not every medical problem requires one. A second opinion may deserve consideration when the diagnosis remains uncertain; symptoms are not adequately explained; the condition is worsening despite appropriate treatment; treatment is not producing the expected response; a major operation or irreversible procedure has been recommended; a proposed treatment has substantial long-term consequences; the diagnosis is unusual or particularly serious; important objective findings appear contradictory; repeated evaluations have not produced a satisfactory explanation; or the diagnosis simply does not explain the complete clinical picture. Seeking another opinion does not necessarily mean that you distrust your physician. In appropriate circumstances, the physician who knows you best may be the person who recommends obtaining one. What If the Second Doctor Disagrees? Disagreement does not automatically tell us which physician is correct. Sometimes additional testing resolves the issue. Sometimes one physician has access to information the other did not. Sometimes a subspecialist brings expertise particularly relevant to the problem. And sometimes medicine contains legitimate uncertainty. The appropriate response is therefore not automatically to choose whichever diagnosis you prefer. Instead, ask: What evidence supports each conclusion? What objective findings fit? What findings do not fit? Is additional testing appropriate? Would another specialist help resolve the discrepancy? Good medicine is not simply about accumulating opinions. It is about understanding the evidence and reasoning behind them. Frequently Asked Questions Will my doctor be offended if I ask for a second opinion? Most physicians understand that second opinions are a normal part of medical care, particularly when a diagnosis remains uncertain or an important treatment decision is being considered. Should I hide my previous diagnosis from the second physician? No. Deliberately withholding medically important information can interfere with safe care. A better approach may be to ask whether the physician can first hear your history and consider the objective findings before concentrating on previous diagnostic impressions. Should I always go to another healthcare system? Not necessarily. Excellent independent reasoning can occur within the same institution. Conversely, simply changing institutions does not guarantee that the assessment will be completely independent. What if the second opinion agrees with the first? That can be an excellent outcome. Confirmation may increase confidence that the diagnosis and treatment plan are reasonable. What if I have already seen several specialists? Several consultations do not necessarily represent several completely independent diagnostic starting points. The more useful question may be whether another evaluation would provide additional expertise or a meaningfully different perspective. What if I find an incorrect diagnosis on my problem list? Ask your physician about it. A useful question is: “Is this still an active diagnosis, and what evidence supports it?” There may be a perfectly reasonable explanation for its presence. If the diagnosis is obsolete or incorrect, discussing it also provides an opportunity to improve the accuracy of your medical record. Bottom Line Modern electronic health records have dramatically improved physicians' ability to share information. That is overwhelmingly useful. But medicine should also recognize a subtle possibility: The same systems that efficiently transmit correct information can also transmit an incorrect or incomplete diagnostic assumption. This does not mean physicians routinely accept previous diagnoses without question. It does not mean electronic health records cause diagnostic errors. And it certainly does not mean every patient needs another opinion. It means that medicine is practiced by human beings, and information encountered early can sometimes influence subsequent reasoning. When a diagnosis remains uncertain, the pieces do not fit, treatment is unsuccessful, or an important medical decision lies ahead, an independent second opinion may provide something particularly valuable: another opportunity to think about the problem from the beginning. Sometimes the second physician reaches exactly the same conclusion. Sometimes the diagnosis changes. Either outcome can be valuable. The purpose of a second opinion should not be to find a physician who agrees with the patient. It should be to give the diagnosis another chance to prove itself. Continue Your Journey to Better Health At Stages of Life Medical Institute, we view diagnosis as a process rather than simply a label. Persistent symptoms frequently require looking at the interaction among multiple physiologic systems and reconsidering assumptions when the clinical picture does not fit. Become a Patient At Stages of Life Medical Institute, our approach begins with careful evaluation of the individual patient rather than simply treating a diagnostic label. Complex or persistent symptoms may require reconsideration of the history, examination, laboratory findings, imaging, medications, metabolic factors, and other physiologic systems contributing to the clinical picture. Our goal is not to disagree with previous physicians. It is to understand why a diagnosis makes sense—and, when appropriate, whether another explanation deserves consideration. Medical Disclaimer This article is intended for educational purposes only and does not substitute for individualized medical diagnosis, treatment, or professional medical advice. Decisions about diagnostic testing, second opinions, medications, supplements, procedures, or other interventions should be made in consultation with an appropriately qualified healthcare professional who understands the patient's individual medical history and circumstances. Our Systems-Based Philosophy At Stages of Life Medical Institute, we believe that symptoms should be considered within the broader context of the patient rather than evaluated solely as isolated diagnoses. Hormonal, metabolic, nutritional, inflammatory, neurologic, cardiovascular, gastrointestinal, and other physiologic systems interact continuously. When symptoms persist or the clinical picture does not fit, reconsidering those relationships may reveal questions that deserve further investigation. References Santhosh L, Cornell E, Rojas JC, et al. Diagnostic Safety Across Transitions of Care Throughout the Healthcare System: Current State and a Call to Action—ED-to-Hospital Transitions. Agency for Healthcare Research and Quality. June 2023. AHRQ Publication No. 23-0040-1-EF. AHRQ full text: Diagnostic Safety Across Transitions of Care — ED-to-Hospital Transitions This is particularly useful for our discussion of diagnostic momentum, anchoring bias, premature closure, and propagation of an early diagnosis. Simon J, Panzer J, Ekong A, Sinsky CA, Wright KM. Checking the Box: The Association between “Problem List Reviewed” and Outdated Diagnoses on the List. Applied Clinical Informatics. 2025;16(5):1779–1786. doi:10.1055/a-2735-0587. PMID: 41265889. PubMed: PMID 41265889 — Simon et al. This directly supports the article's concern that problem lists can contain outdated diagnoses despite being documented as reviewed. Payne VL, Singh H, Meyer AND, Levy L, Harrison D, Graber ML. Patient-Initiated Second Opinions: Systematic Review of Characteristics and Impact on Diagnosis, Treatment, and Satisfaction. Mayo Clinic Proceedings. 2014;89(5):687–696. doi:10.1016/j.mayocp.2014.02.015. PMID: 24797646. PubMed: PMID 24797646 — Payne et al. The systematic review found that second opinions commonly confirmed the original assessment, but a meaningful subset produced major changes in diagnosis, treatment, or prognosis. Greenfield G, Shmueli L, Harvey A, Quezada-Yamamoto H, Davidovitch N, Pliskin JS, et al. Patient-initiated second medical consultations—patient characteristics and motivating factors, impact on care and satisfaction: a systematic review. BMJ Open. 2021;11(9):e044033. doi:10.1136/bmjopen-2020-044033. PMID: 34561250. PubMed: PMID 34561250 — Greenfield et al. Free full text: PMC8475134 — Full Article This reference is especially valuable because it reviews 33 studies and addresses why patients seek second opinions as well as their effects on diagnosis, management, and satisfaction. Meyer AND, Singh H, Graber ML. Evaluation of Outcomes From a National Patient-Initiated Second-Opinion Program. American Journal of Medicine. 2015;128(10):1138.e25–1138.e33. doi:10.1016/j.amjmed.2015.04.020. PMID: 25913850. PubMed: PMID 25913850 — Meyer, Singh & Graber This study specifically evaluated outcomes from a national second-opinion program, including whether the second assessment confirmed, clarified, or changed the original diagnosis and treatment. © 2026 Stages of Life Medical Institute • Version 1.0 • September 2026 The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Could you be running low on glycine? Glycine supports restorative sleep, healthy metabolism, collagen and connective tissue, glutathione antioxidant defense, and healthy aging. Stages of Life Medical Institute explores the emerging concept of subclinical or functional glycine insufficiency. The Subclinical Signs of Inadequate Glycine Availability Quick Look Glycine is usually classified as a nonessential amino acid because the human body can manufacture it. But “nonessential” does not mean unimportant—or that the body necessarily produces enough for every circumstance. Glycine is required for collagen formation, glutathione synthesis, creatine production, neurotransmission, heme and purine synthesis, bile-acid conjugation, and several other metabolic processes.¹⁻⁴ The intriguing question is whether glycine production and dietary intake always keep pace with demand, particularly during aging, metabolic dysfunction, oxidative stress, or increased connective-tissue turnover. There is no formally recognized medical diagnosis called subclinical glycine deficiency, and there is no single laboratory value or symptom pattern that establishes it. A more scientifically appropriate concept is relative or functional glycine insufficiency: Glycine supply < metabolic demand That distinction may be clinically important. Glycine: A Small Amino Acid With an Enormous Job Glycine is the smallest amino acid used to build human proteins. Its unusually simple structure allows it to fit into places within proteins where larger amino acids cannot. This is particularly important in collagen. Approximately every third amino-acid residue in collagen is glycine. Collagen, in turn, is the major structural protein of: Skin Bone Cartilage Tendons Ligaments Fascia Blood vessels Intervertebral discs Maintaining and repairing this enormous connective-tissue network creates a substantial lifelong requirement for glycine. But collagen is only part of the story. Glycine is also required to manufacture glutathione, one of our most important intracellular antioxidants. It participates in creatine synthesis, heme production, purine synthesis, one-carbon metabolism, bile-acid conjugation, and several hepatic metabolic pathways.¹⁻⁴ It also functions as a neurotransmitter. Consequently, many biological systems depend upon this deceptively simple molecule. If We Make Glycine, How Could We Run Low? The body manufactures glycine primarily from serine. That is why glycine has traditionally been considered nonessential. But two very different questions are involved: Can the body manufacture glycine? Yes. Can it always manufacture enough to satisfy every metabolic requirement? That is less certain. Investigators examining whole-body glycine requirements have proposed that endogenous synthesis may not always satisfy the amount required for collagen synthesis and other metabolic functions. The exact magnitude of this proposed “glycine deficit” remains debated and should not be interpreted as an established dietary requirement. Nevertheless, it raises an important physiological principle: Being able to manufacture a nutrient does not guarantee that the rate of production will always satisfy metabolic demand. For this reason, glycine has sometimes been described as a conditionally essential amino acid.¹,² What Is Subclinical Glycine Insufficiency? There is currently no accepted medical diagnosis called subclinical glycine deficiency. Instead, we are considering a possible state of relative glycine insufficiency. A person's protein intake might appear adequate and the blood glycine concentration might not be dramatically abnormal, yet glycine availability could potentially become limiting for particular biochemical pathways. This concept becomes especially interesting with: Aging Insulin resistance Obesity Type 2 diabetes Metabolic liver disease Chronic oxidative stress Increased connective-tissue turnover Injury recovery Low dietary intake of glycine-rich foods Low circulating glycine is consistently observed in obesity, insulin resistance, and type 2 diabetes.¹,⁴,⁵ This does not establish that inadequate glycine causes these diseases. The relationship may operate in both directions. Metabolic dysfunction may alter glycine synthesis, utilization, degradation, and other aspects of amino-acid metabolism. Reduced glycine availability might then further influence metabolic resilience. L-Glycine 500 mg Capsules bottle of 240 L-Glycine 500 mg Capsules bottle of 240 Could Low Glycine Produce Symptoms? Possibly—but this requires considerable caution. There is no validated “glycine deficiency symptom checklist.” Symptoms potentially associated with inadequate glycine availability are nonspecific and have many alternative explanations. Nevertheless, several clinical patterns are biologically plausible. 1. Poor or Nonrestorative Sleep Glycine participates in central nervous-system signaling and thermoregulation. Small human studies using approximately 3 grams before bedtime have reported improvements in subjective sleep quality, fatigue, and next-day performance.⁶,⁷ Glycine may facilitate the normal decline in core body temperature that accompanies sleep rather than acting like a conventional sedative. Possible clues might include: Nonrestorative sleep Morning fatigue Daytime sleepiness Feeling poorly recovered despite adequate time in bed These symptoms certainly do not diagnose glycine insufficiency. Persistent sleep problems require evaluation for conditions such as sleep apnea, restless legs syndrome, pain, thyroid dysfunction, medication effects, alcohol use, depression, and other causes. 2. Declining Connective-Tissue Resilience Collagen creates an unusually large glycine requirement. With aging, we commonly experience: Stiffer joints Reduced skin resilience Tendon discomfort Slower musculoskeletal recovery Reduced tissue elasticity These findings have numerous potential causes and do not establish glycine insufficiency. Nevertheless, because approximately one-third of collagen residues are glycine, connective-tissue turnover represents an important component of whole-body glycine demand. Modern diets may also differ from traditional diets. Many people eat primarily lean muscle meat, while consuming relatively little skin, cartilage, tendons, gelatin, or other connective tissues that are particularly rich in glycine. That change in amino-acid intake may be physiologically relevant. 3. Metabolic Dysfunction Perhaps the most consistent clinical association with low glycine involves metabolic health. Lower circulating glycine concentrations are repeatedly associated with: Insulin resistance Obesity Metabolic syndrome Type 2 diabetes Metabolic dysfunction-associated steatotic liver disease. (Fatty Liver) Prospective studies have also found that lower glycine concentrations can precede the development of type 2 diabetes.⁵ This does not mean that glycine supplementation treats diabetes. Instead, circulating glycine may provide another biochemical clue that the metabolic system is under stress. 4. Reduced Antioxidant Reserve Glycine is one of three amino acids required to manufacture glutathione: Glutamate + Cysteine + Glycine → Glutathione Glutathione is one of the body's principal intracellular antioxidant systems. As oxidative demand increases, precursor availability becomes increasingly important. Aging, metabolic dysfunction, chronic inflammation, and other physiological stressors may increase oxidative burden. If glycine or cysteine availability becomes limiting, glutathione synthesis can potentially become constrained.⁸,⁹ This observation led to considerable interest in combining glycine with N-acetylcysteine (NAC). Aging May Change the Equation Aging may be one of the most important settings in which glycine availability deserves consideration. Older adults frequently experience simultaneous increases in: Oxidative stress Mitochondrial dysfunction Insulin resistance Inflammation Connective-tissue degeneration Loss of muscle and physical function An isotope-tracer study comparing younger and older adults found substantially lower red-blood-cell glycine, cysteine, and glutathione concentrations in the older group, accompanied by impaired glutathione synthesis and greater oxidative stress. Supplementation with glycine and cysteine restored glutathione synthesis and substantially reduced measured oxidative stress.⁸ This work helped stimulate research into GlyNAC—glycine combined with N-acetylcysteine. A randomized clinical trial in older adults subsequently reported improvements in glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, inflammation, and several measures of physical function with GlyNAC supplementation.¹⁰ These findings are intriguing but should not be interpreted as proof that GlyNAC is an established anti-aging therapy. Larger and longer clinical trials with meaningful clinical outcomes remain necessary. Clinical Pearl Nutritional therapy may work best when it corrects a limitation that is actually present. Giving additional nutrients to someone who already has adequate availability may accomplish very little. The more sophisticated question is therefore not simply: “Does glycine work?” It is: “Which patient has a physiological situation in which glycine availability may have become limiting?” That distinction is central to individualized nutritional medicine. Can We Measure Glycine? Yes. Glycine can be measured as part of a plasma amino-acid profile. However, there is currently no universally accepted plasma concentration that diagnoses functional or subclinical glycine insufficiency. A plasma concentration also represents only one compartment of whole-body glycine metabolism. A value within a laboratory reference interval does not necessarily tell us whether glycine availability is optimal for collagen synthesis, glutathione production, neurotransmission, or tissue repair. Likewise, a low value may reflect metabolic disease rather than inadequate dietary intake. Testing therefore requires clinical context. What Your Doctor May Evaluate Before Recommending Glycine At Stages of Life Medical Institute, nutritional therapy is most useful when incorporated into a broader assessment of physiology. System What May Be Evaluated Glucose metabolism Fasting glucose, insulin, hemoglobin A1c, insulin resistance Liver Liver enzymes and evidence of metabolic liver disease Kidney Creatinine, estimated GFR and renal function Nutrition Protein intake and overall dietary pattern Amino acids Plasma amino-acid profile when appropriate Sleep Sleep duration, quality, apnea risk and medications Connective tissue Joint, tendon, skin and musculoskeletal health Muscle Strength, activity, protein intake and sarcopenia risk Medications Drugs and supplements affecting sleep, fatigue or metabolism The objective is not simply to decide whether someone should take glycine. It is to determine why the patient's physiology has changed. Where Do We Get Glycine? Particularly rich dietary sources include: Gelatin Collagen Skin and connective tissue from meat and poultry Slow-cooked connective-tissue-rich meats Fish skin Pork skin Muscle meat also contains glycine, but its amino-acid profile differs considerably from collagen-rich tissue. Glycine Versus Collagen Peptides They are related but not interchangeable. Free Glycine Collagen Peptides Provides a precise glycine dose Provides glycine plus proline, hydroxyproline and collagen-derived peptides Useful when glycine itself is the target Particularly attractive for connective-tissue support Inexpensive and easy to mix Provides a broader collagen-building substrate Commonly studied for bedtime use Often used for skin, tendon, ligament and joint support For systemic glycine supplementation or bedtime use, free glycine offers dosing precision. When connective tissue is the principal objective, collagen peptides provide a broader collection of structural substrates. How Much Glycine? There is no established Recommended Dietary Allowance specifically for glycine. For sleep, a commonly studied amount is: 3 grams approximately 30–60 minutes before bedtime.⁶,⁷ For general nutritional supplementation, 3–5 grams daily is commonly used, although this should not be interpreted as an established therapeutic requirement. Research protocols involving GlyNAC have sometimes used substantially larger doses. Those research doses should not automatically be translated into routine self-supplementation. More is not necessarily better. Glycine or GlyNAC? Glycine alone may be considered when the objective is increasing dietary glycine, sleep support, glycine-specific nutritional repletion, or supporting collagen substrate availability. GlyNAC provides glycine together with a cysteine precursor and has principally been investigated for: Glutathione synthesis Oxidative stress Mitochondrial physiology Insulin resistance Aging-related metabolic changes At present, GlyNAC should be viewed as an interesting and evolving clinical research strategy, not a proven longevity treatment. Who Might Reasonably Discuss Glycine With Their Physician? Consideration may be reasonable in selected adults with: Low intake of collagen-rich foods Poor-quality or nonrestorative sleep Increasing age Insulin resistance or metabolic dysfunction Increased oxidative stress High connective-tissue demands Low circulating glycine on an amino-acid profile None of these automatically establishes a need for supplementation. They simply provide reasons to consider glycine within the larger physiological picture. Safety and Cautions Glycine is generally well tolerated at commonly used nutritional amounts. Possible adverse effects include gastrointestinal discomfort, nausea, bloating, or loose stools, particularly at larger doses. Medical guidance is particularly appropriate for people with significant kidney or liver disease, pregnancy or breastfeeding, complex medication regimens, serious neurological or psychiatric disorders, or known amino-acid/metabolic abnormalities. Supplement quality and purity also matter. Frequently Asked Questions Is glycine deficiency a recognized disease? Not in the way iron or vitamin B12 deficiency is recognized. The more appropriate concept is relative or functional glycine insufficiency, in which glycine availability may be inadequate relative to metabolic demand. Can a blood test diagnose it? Plasma amino-acid testing can measure glycine, but there is currently no universally accepted concentration defining subclinical glycine insufficiency. Is glycine the same as collagen? No. Glycine is an individual amino acid. Collagen is a large structural protein that is exceptionally rich in glycine. Can I get glycine from food? Yes. Gelatin, collagen, skin, and connective-tissue-rich foods are particularly good sources. Can glycine help sleep? Small human studies suggest approximately 3 grams before bedtime may improve certain measures of sleep quality, fatigue, and next-day performance.⁶,⁷ The evidence remains much smaller than that supporting established treatments for sleep disorders. Is GlyNAC better than glycine alone? Not necessarily. GlyNAC provides glycine together with a cysteine precursor and has principally been studied for glutathione, oxidative stress, mitochondrial physiology, and aging. Does glycine treat diabetes? No. Lower circulating glycine is associated with insulin resistance and type 2 diabetes, but supplementation should not replace established nutritional, exercise, weight-management, or medical treatment. Should everyone over age 60 take glycine? There is insufficient evidence to recommend universal supplementation based solely upon age. The Bottom Line Glycine occupies an unusual position in human nutrition. It is technically a nonessential amino acid, yet it participates in some of the body's most fundamental processes: collagen formation, glutathione synthesis, creatine production, neurotransmission, metabolic regulation, and cellular defense. The human body can manufacture glycine. The more interesting question is whether it always manufactures enough. Current evidence does not justify diagnosing a widespread epidemic of glycine deficiency, nor should nonspecific symptoms automatically be treated with glycine without investigating their underlying causes. But the evidence supports a more nuanced possibility: Some individuals—particularly during aging, metabolic dysfunction, oxidative stress, or increased tissue demand—may develop a mismatch between glycine availability and glycine requirements. For these individuals, dietary assessment, metabolic evaluation, and carefully selected supplementation may be reasonable. The objective is not simply to add another supplement. It is to identify where physiology has become limiting and determine whether correcting that limitation improves function. Continue Your Journey to Better Health Glycine biology intersects with sleep, metabolism, oxidative stress, cardiovascular health, and healthy aging. These related Stages of Life Medical Institute articles explore those connections further. L-Glycine: An Overlooked Amino Acid for Sleep, Anxiety, Recovery, and Longevity. A companion article examining glycine's broader potential roles in sleep, connective-tissue repair, metabolic health, glutathione production, and longevity. The Longevity Pulse: What Your Resting Heart Rate Says About Your Health Explore how resting heart rate can reflect cardiovascular fitness, autonomic balance, sleep, inflammation, metabolic health, and physiological resilience. Pulse Pressure, Aging, and Stroke Risk: Why the “Ideal” Number Changes With Age Learn about vascular aging, arterial stiffness, blood pressure, and their relationship to cardiovascular and stroke risk. Uric Acid and Hypertension: Is Your Uric Acid Helping Drive Your Blood Pressure? Explore the connections among uric acid, oxidative stress, nitric oxide, kidney function, insulin resistance, and hypertension. Uric Acid and Longevity: Live Longer by Keeping the Level below 5.5 mg/dL Examine another metabolic marker associated with vascular health, insulin resistance, and healthy aging. Become a Patient At Stages of Life Medical Institute, we believe symptoms should be investigated rather than simply suppressed. Fatigue, poor sleep, metabolic dysfunction, loss of physical resilience, and changes associated with aging frequently involve several interacting systems. Nutritional status is one component—but rarely the entire explanation. Our approach is to evaluate the underlying physiology, identify correctable abnormalities, and develop an individualized treatment strategy based upon the patient's findings rather than treating an isolated laboratory number or following the latest supplement trend. Stages of Life Medical Institute, Longwood, Florida Our Root-Cause Perspective At Stages of Life Medical Institute, nutritional interventions are considered within the larger interaction among metabolic health, hormonal function, inflammation, sleep, mitochondrial function, diet, physical activity, and aging. The goal is not simply to supplement glycine. The goal is to understand why the patient's physiology may require additional support in the first place. References Alves A, Bassot A, Bulteau AL, Pirola L, Morio B. Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. Nutrients. 2019;11(6):1356. PMID: 31208147. Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G. Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013;45(3):463–477. PMID: 23615880. Razak MA, Begum PS, Viswanath B, Rajagopal S. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid Med Cell Longev. 2017;2017:1716701. PMID: 28337245. Alves A, Morio B. Alterations in glycine metabolism in obesity and chronic metabolic diseases—an update on new advances. Curr Opin Clin Nutr Metab Care. 2023;26(1):50–54. PMID: 36542534. Adeva-Andany MM, et al. Insulin resistance and glycine metabolism in humans. Amino Acids. 2018;50:11–27. PMID: 29094215. Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012;118(2):145–148. PMID: 22293292. Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Front Neurol. 2012;3:61. PMID: 22529837. Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94(3):847–853. PMID: 21795440. Sekhar RV, McKay SV, Patel SG, et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011;34(1):162–167. PMID: 20929994. Kumar P, Liu C, Suliburk J, et al. Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75–89. PMID: 35975308. Medical Disclaimer: This article is intended for educational purposes and does not substitute for individualized medical diagnosis or treatment. Nutritional supplements should be considered in the context of medical history, medications, laboratory findings, kidney and liver function, and individual clinical circumstances. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com © 2026 Stages of Life Medical Institute. All rights reserved.

Why Hot Weather Can Increase Dizziness and Fall Risk Figure 1. Environmental heat, sweating, alcohol, medications, and fluid imbalance can interact to increase the risk of hyponatremia, orthostatic dizziness, impaired balance, and falls—particularly in older adults. Quick Look Hot weather, sweating, alcohol, medications, and fluid intake can interact in ways that are much more complicated than simple “dehydration.” During prolonged heat exposure, a person may lose both water and sodium through perspiration. Heat also dilates blood vessels near the skin, which can lower blood pressure and make standing more difficult. Add alcohol—which can impair balance, judgment, coordination, and normal cardiovascular responses—and the risk of dizziness or a fall increases. Then comes an important paradox: drinking large quantities of plain water is not always the solution. If substantial sodium-containing fluid has been lost and water is consumed faster than the kidneys can eliminate it, serum sodium can fall. This is hyponatremia, generally defined as a serum sodium concentration below 135 mmol/L.¹ Older adults are particularly vulnerable because aging, medications, reduced kidney reserve, cardiovascular disease, and baseline balance problems can narrow the margin of safety. Even relatively mild chronic hyponatremia has been associated with measurable disturbances of attention and gait and an increased incidence of falls.² The important message: Dizziness during hot weather does not necessarily mean that you simply need more water. Heat Changes More Than Your Temperature. Hyponatremia Complicated by Alcohol The human body depends heavily on sweating and increased blood flow to the skin to dissipate excess heat. Sweat contains water, but it also contains electrolytes—most importantly sodium and chloride. The amount of sodium lost varies considerably among individuals and depends on factors such as sweating rate, heat acclimatization, exercise intensity, duration of exposure, and individual physiology. A person working outdoors, gardening, playing golf, exercising, or simply spending several hours outside in very hot weather can therefore lose substantial amounts of both water and sodium. Think about the way you enjoy playing golf............ At the same time, heat causes blood vessels supplying the skin to dilate. That is useful for cooling, but it creates a cardiovascular challenge. If circulating blood volume has already fallen because of sweating, less blood may return to the heart when the person stands. Blood pressure can fall. The person may become lightheaded. And a fall may follow. This sequence is particularly important because orthostatic dizziness can occur without hyponatremia. Heat-related volume depletion and vasodilation can cause symptoms before the serum sodium concentration becomes abnormal. That distinction is important throughout this discussion. Then, Add Alcohol: environmental heat alcohol hyponatremia Alcohol introduces another layer of risk. Even before considering sodium, alcohol can impair balance, reaction time, coordination, attention, and judgment. Those effects alone can increase the likelihood of falling. Alcohol can also alter vascular and autonomic responses involved in maintaining blood pressure. In someone who is already hot, sweating, taking blood-pressure medication, or somewhat volume depleted, the combined effect can make standing and walking more difficult. Consider a common scenario: A person spends several hours outside on a hot afternoon. He has been sweating substantially. He drinks several alcoholic beverages. He eats relatively little. Because he has repeatedly heard that he must “stay hydrated,” he also drinks large quantities of plain water. Later, he gets out of a chair quickly. He becomes dizzy, loses his balance, and falls. It would be tempting to label the entire episode dehydration. That may be wrong. Several different physiologic problems may be occurring at the same time. Sodium Is About Water Balance, Not Just Salt This is one of the most important concepts in understanding hyponatremia. Hyponatremia does not simply mean that the body has “run out of salt.” Serum sodium is a concentration. It reflects the relationship between body water and the body's exchangeable sodium and potassium. Consequently, the sodium concentration can become low because sodium has been lost, because too much water has been retained, or because both processes are occurring simultaneously.¹ Again, environmental heat, alcohol hyponatremia. That explains why two people with exactly the same serum sodium concentration may have very different underlying problems. One may be volume depleted. Another may have retained too much water. A third may have a combination of sodium loss and impaired water excretion. The treatment is therefore not necessarily the same. The Hot-Weather Water Paradox Imagine losing a substantial amount of salty fluid through perspiration and then replacing those losses almost exclusively with plain water. You have replaced water, but you have not proportionately replaced the electrolytes that were lost. Even then, hyponatremia will not necessarily develop. Healthy kidneys have an impressive ability to eliminate excess water. The problem arises when water intake exceeds the body's ability to excrete water. That ability can be reduced by several factors: Older age Certain medications Reduced kidney function Very low dietary solute intake Nausea, pain, or physiologic stress that stimulates vasopressin Continued drinking beyond physiologic need This principle is particularly well established in exercise-associated hyponatremia, in which excessive hypotonic fluid consumption relative to renal water excretion is a major contributor. International consensus recommendations have therefore emphasized avoiding overdrinking and using thirst as an important guide during exercise rather than attempting to replace every estimated milliliter of fluid lost.³ The broader lesson applies well beyond marathon runners: More water is not automatically better hydration. Figure 2. Falling serum sodium levels may progress from subtle changes in attention and gait to nausea, headache, confusion, instability, seizures, and collapse. Even mild chronic hyponatremia has been associated with increased fall risk, particularly in older adults. Not Every Hot-Weather Dizzy Spell Is the Same Condition What May Be Happening Common Clues Volume depletion Loss of water and circulating volume Thirst, weakness, faster pulse, reduced urine Orthostatic hypotension Blood pressure falls after standing Lightheadedness, dimming vision, near-fainting Heat exhaustion Heat stress plus cardiovascular and fluid disturbances Heavy sweating, weakness, nausea, headache, dizziness Hyponatremia Sodium concentration is too low relative to body water Nausea, headache, fatigue, confusion, gait disturbance Alcohol-related impairment Balance, reaction time, judgment and cardiovascular compensation may deteriorate Unsteadiness, slower responses, impaired decision-making The critical point is that these conditions are not mutually exclusive. A patient can be mildly volume depleted, orthostatic, hyponatremic, and experiencing the effects of alcohol simultaneously. That is precisely why “drink more water” is an inadequate diagnostic strategy for every person who becomes dizzy during hot weather. Why Older Adults Deserve Special Attention The margin for physiologic error generally becomes smaller with age. Older adults are more likely to have multiple medical conditions, take several medications, experience impaired renal water handling, and have less cardiovascular reserve. They may also begin with some degree of visual impairment, neuropathy, muscle weakness, vestibular dysfunction, or gait instability. Then add heat. Add a medication that lowers blood pressure. Add a diuretic. Add an alcoholic beverage. Add rapid standing. And, perhaps, add a dip in the 'Hot tub.' Finally, add even a modest disturbance in serum sodium. What might have produced temporary lightheadedness in a younger person may now result in a fall, fracture, or hospitalization. 'There is particularly compelling evidence connecting chronic hyponatremia with falls. In a frequently cited study, patients with mild chronic hyponatremia demonstrated measurable abnormalities in both gait and attention, and falls were substantially more common than among matched controls. The investigators also found that some of the measured impairments were comparable to those observed after alcohol intake.² That observation makes the combination of hyponatremia plus alcohol especially relevant when discussing fall prevention. Medications Can Change the Equation One of the first questions we should ask when an older patient repeatedly becomes dizzy during hot weather is: What medications are you taking? Thiazide Diuretics Thiazide and thiazide-like diuretics—including medications such as hydrochlorothiazide, chlorthalidone, and indapamide—are effective treatments for hypertension. They are also among the important medication-related causes of hyponatremia in older adults.⁴˒⁵ Thiazides interfere with sodium and chloride transport in the kidney's distal diluting segment. In susceptible individuals, this reduces the kidney's ability to excrete maximally dilute urine.⁵ An important clinical point is that thiazide-associated hyponatremia does not necessarily occur only when treatment is first started. A patient may tolerate a thiazide for months or even years and then develop hyponatremia when another factor changes—for example: Kidney function declines Water intake increases substantially Dietary sodium or solute intake changes Another medication is added An illness develops Environmental heat substantially changes fluid intake and losses This delayed vulnerability has been recognized in the clinical literature.⁴ Other medications can contribute as well. These include certain antidepressants and other drugs that influence vasopressin activity or renal water handling.⁴ The solution is not for patients to stop prescribed medications whenever the weather becomes hot. The solution is to recognize that recurrent heat-associated dizziness deserves an individualized evaluation rather than a generic instruction to drink more water. Clinical Pearl Dizziness during hot weather is not synonymous with dehydration. In an older adult—particularly someone taking a thiazide diuretic or another medication associated with hyponatremia—drinking progressively larger quantities of plain water while continuing to sweat may not correct the underlying problem. Under the wrong circumstances, it can contribute to a further decline in serum sodium. Instead of asking only: “Have you been drinking enough water?” we should ask: “What have you been losing, what have you been drinking, what have you been eating, what medications are you taking, and how is your body handling the combination?” That is a much better starting point. Figure 3. Hot-weather safety requires more than simply drinking additional water. Appropriate fluid and sodium replacement during prolonged sweating, limiting alcohol, maintaining good nutrition, reviewing medications, standing slowly, and recognizing warning signs can reduce the risk of dizziness, hyponatremia, and falls—particularly in older adults Alcohol, Sodium, and Falls: When Several Small Risks Become One Big Risk Alcohol can become especially important when several of these physiologic stresses occur simultaneously. Alcohol Can Make Orthostatic Hypotension Worse When we stand, gravity temporarily shifts blood toward the legs and abdomen. The body normally compensates almost immediately. Blood vessels constrict, heart rate adjusts, and blood pressure is maintained so adequate blood continues to reach the brain. Alcohol can interfere with this compensatory response. Controlled research has demonstrated that alcohol can potentiate the fall in blood pressure during orthostatic stress and impair normal vasoconstriction.⁶ Now combine alcohol with environmental heat. Heat has already increased blood flow to the skin. Sweating may have reduced circulating volume. A blood-pressure medication or diuretic may further reduce cardiovascular reserve. Then alcohol is added. The result may be: Heat + sweating + vasodilation + alcohol + standing → blood-pressure drop → dizziness → loss of balance → fall Importantly, this can occur without severe hyponatremia. Alcohol and Hyponatremia: Two Problems at Once Alcohol does not automatically cause hyponatremia. Instead, it can become one component of an environment that favors instability. Alcohol may impair judgment about how much to drink, what to drink, whether to eat, and whether symptoms such as dizziness or weakness should be taken seriously. Alcohol itself can also impair coordination and balance. Now add hyponatremia. The nervous system may be affected from two directions: Alcohol → impaired balance, reaction time, judgment, and postural responses Hyponatremia → impaired attention, gait, and neurologic function This helps explain why someone who appears only mildly ill can nevertheless have substantial fall risk. The Special Case of Beer and Low-Solute Intake There is another relationship between alcohol and sodium that deserves discussion: beer potomania. The name is unusual, but the physiology is important. Beer contains considerable water but relatively little sodium, protein, or other solute. When someone consumes large quantities of beer while eating very little food, the kidneys may receive insufficient dietary solute to eliminate the accompanying water efficiently. The kidney does not simply eliminate unlimited quantities of water. Its capacity to excrete water partly depends on the amount of solute available for urinary excretion. When dietary protein and electrolyte intake becomes extremely low, the amount of water that can be safely eliminated may decline substantially. Combine: Large quantities of beer + very little food + low solute intake and severe dilutional hyponatremia can develop.⁷˒⁸ This does not mean that having a beer after playing golf causes beer potomania. The classic syndrome generally involves much greater alcohol consumption combined with inadequate nutrition. But the underlying lesson is useful: Water balance depends upon more than how much fluid you drink. What you eat matters too. Why Mild Hyponatremia Should Not Always Be Dismissed For many years, mild chronic hyponatremia was sometimes regarded as an incidental laboratory abnormality. Evidence has challenged that assumption. A systematic review and meta-analysis involving more than 51,000 patients found that hyponatremia was associated with significantly increased risks of falls and fractures.⁹ The consequences become particularly important in older adults. A fall at age 30 may produce a bruise. A fall at age 80 may produce: Hip fracture Head injury Hospitalization Loss of mobility Loss of independence Rehabilitation or nursing-home placement A systematic review examining aging-related disease also found a consistent association between hyponatremia and falls while appropriately emphasizing that falls are multifactorial.¹⁰ That distinction matters. Hyponatremia should be considered a potential contributor to fall risk—not automatically assumed to be the explanation for every fall. Antidepressants Can Add Another Layer Thiazide diuretics are not the only medications worth considering. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) can also be associated with hyponatremia, particularly in older adults.¹¹˒¹² Risk can become especially relevant when other predisposing factors are present, including advanced age, lower baseline sodium, and simultaneous use of diuretics. This creates another clinically important combination: Older age + thiazide diuretic + antidepressant + heat + sweating + increased water intake No single factor necessarily produces hyponatremia. The combination may substantially change risk. Patients should not discontinue these medications on their own. Recurrent dizziness, falls, confusion, or documented low sodium should instead prompt medication review and appropriate laboratory evaluation. What Your Doctor May Evaluate Before Recommending Treatment Diagnosis is much more useful than simply giving generic hydration advice. For recurrent dizziness, weakness, instability, or falls during hot weather, your physician may evaluate several interacting systems. Blood Pressure and Circulation Evaluation may include: Seated and standing blood pressure Heart rate Orthostatic blood-pressure changes Cardiovascular examination Evidence of volume depletion Review of antihypertensive medications Electrolytes and Kidney Function Laboratory testing may include: Serum sodium Potassium Chloride Bicarbonate Blood urea nitrogen Creatinine and estimated GFR Glucose Serum osmolality when appropriate If hyponatremia is confirmed, additional evaluation may include urine osmolality, urine sodium, thyroid function, adrenal evaluation, and other testing according to the clinical circumstances.¹˒¹³ Medication Review Particular attention may be given to: Thiazide and thiazide-like diuretics SSRIs and SNRIs Other medications associated with SIADH Antihypertensive medications Medications affecting kidney function Multiple medications acting together Nutrition, Alcohol, and Fluid Intake The history matters. Your doctor may ask: How much water are you drinking? Are you using electrolyte beverages? How heavily are you sweating? How much alcohol are you consuming? Are you eating normally? Have you intentionally reduced your salt intake? Those questions can sometimes reveal more than the sodium value itself. When Dizziness Becomes an Emergency Most episodes of mild heat-related lightheadedness do not represent severe hyponatremia. Certain symptoms, however, should change the response immediately. Seek urgent medical evaluation for: New confusion Significant change in behavior or mental status Severe or worsening headache Repeated vomiting Marked difficulty walking Collapse or loss of consciousness Seizure Profound weakness Severe lethargy or unusual difficulty awakening Suspected heat stroke Severe symptomatic hyponatremia is a medical emergency. It should not be treated at home by simply drinking salt water, taking large amounts of salt tablets, restricting fluids, or consuming large quantities of electrolyte solution. Appropriate treatment depends upon the cause, severity, duration, symptoms, and underlying medical conditions. Treatment must also avoid correcting chronic hyponatremia too rapidly because overly rapid correction can cause serious neurologic injury.¹˒¹³ Confusion, seizure, collapse, or major neurologic change during heat exposure requires medical assessment—not experimentation with fluids or salt at home. Frequently Asked Questions If I feel dizzy outside, should I immediately drink water? Not necessarily. If you have been exercising or sweating, fluid may certainly be needed. But dizziness can also result from orthostatic hypotension, medications, alcohol, heat illness, cardiac problems, or hyponatremia. The circumstances matter. Should I drink electrolyte beverages instead of water during hot weather? Not routinely. For ordinary daily activity and limited heat exposure, normal meals and water are usually sufficient for healthy people. During prolonged heavy sweating, electrolyte replacement becomes more relevant because sweat contains both water and sodium. People with hypertension, heart failure, kidney disease, fluid restrictions, or prescribed sodium restrictions should obtain individualized recommendations. Can drinking too much water actually be dangerous? Yes. Excessive consumption of hypotonic fluid can lower serum sodium when water intake exceeds the body's ability to eliminate it. This is particularly well recognized during prolonged endurance activity but can occur in other settings.³ Does alcohol dehydrate everyone? The relationship is more complicated than the familiar statement that “alcohol dehydrates you.” For the subject of falls, the more clinically useful point is that alcohol can impair balance and judgment and can interfere with the cardiovascular response to standing.⁶ When combined with heat, sweating, medications, and abnormal sodium balance, those effects become more important. Should I stop my diuretic or blood-pressure medicine when it is extremely hot? Do not stop a prescribed medication simply because the temperature rises unless your clinician has given you a specific plan. People who repeatedly experience dizziness, unusually low blood pressure, falls, or electrolyte abnormalities during hot weather should discuss their medications and hydration strategy with their physician. Can mild hyponatremia really increase fall risk? There is a consistent association between hyponatremia and falls, particularly among older adults.²˒⁹˒¹⁰ However, falls are multifactorial. Sodium may be one contributor among blood pressure, medications, vision, neuropathy, muscle strength, alcohol, vestibular function, and environmental hazards. That is why a systems-based evaluation is preferable to focusing on one laboratory number. The Bottom Line Environmental heat changes the body's physiology. Sweating removes water and sodium. Heat dilates blood vessels. Volume depletion can make blood pressure fall when you stand. Alcohol can further impair balance, judgment, coordination, and normal cardiovascular compensation. Certain medications can increase susceptibility to either orthostatic hypotension or hyponatremia. And excessive replacement with plain water can occasionally compound the problem rather than solve it. Put those factors together and a seemingly simple summer complaint— “I got dizzy when I stood up.” —can represent a much more complicated physiologic event. The goal should therefore not be to drink the greatest possible amount of water. The goal is to replace what you are actually losing, avoid overdrinking, maintain appropriate nutrition, understand how your medications affect fluid and sodium balance, limit alcohol during significant heat exposure, and recognize symptoms that require medical evaluation. For older adults in particular, preventing the dizzy spell may also mean preventing the fall that follows it. Continue Your Journey to Better Health Health problems rarely occur in isolation. Heat tolerance, blood pressure, kidney function, sodium balance, cardiovascular health, nutrition, medications, and aging physiology all interact. These Stages of Life Medical Institute articles explore several of those connections: Extreme Heat, Heavy Sweating, and Salt Loss: When Water Is Not Enough Pulse Pressure, Aging, and Stroke Risk: Why the “Ideal” Number Changes With Age The Longevity Pulse: What Your Resting Heart Rate Says About Your Health Uric Acid and Hypertension: Is Your Uric Acid Helping Drive Your Blood Pressure? Uric Acid and Nitric Oxide: The Hidden Driver of Endothelial Dysfunction and Vascular Disease Uric Acid and Longevity: Live Longer by Keeping the Level below 5.5 mg/dL Become a Patient At Stages of Life Medical Institute, we look beyond a single symptom or laboratory value. Recurrent dizziness, unexplained falls, low blood pressure, abnormal sodium levels, medication effects, kidney function, cardiovascular health, nutrition, and fluid balance may all be pieces of the same puzzle. A systems-based evaluation can help determine why the problem is occurring rather than simply treating every episode as dehydration. Our Philosophy At Stages of Life Medical Institute, we believe symptoms should be evaluated within the context of the whole patient. Fluid balance, electrolytes, kidney function, cardiovascular physiology, medications, nutrition, hormones, metabolism, and lifestyle frequently interact. Identifying those relationships allows treatment to focus on the underlying physiology rather than a symptom alone. References 1. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology. 2014;170(3):G1–G47.PubMed: Clinical Practice Guideline on Diagnosis and Treatment of Hyponatraemia 2. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. American Journal of Medicine. 2006;119(1):71.e1–71.e8.PubMed: Mild Chronic Hyponatremia, Falls, Unsteadiness and Attention Deficits 3. Hew-Butler T, Rosner MH, Fowkes-Godek S, et al. Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015. Clinical Journal of Sport Medicine. 2015;25(4):303–320.PubMed: Exercise-Associated Hyponatremia Consensus Statement 4. Liamis G, Filippatos TD, Elisaf MS. Thiazide-associated hyponatremia in the elderly: what the clinician needs to know. Journal of Geriatric Cardiology. 2016;13(2):175–182.PubMed: Thiazide-Associated Hyponatremia in the Elderly 5. Hwang KS, Kim GH. Thiazide-induced hyponatremia. Electrolyte & Blood Pressure. 2010;8(1):51–57.PubMed: Thiazide-Induced Hyponatremia 6. Narkiewicz K, Cooley RL, Somers VK. Alcohol potentiates orthostatic hypotension: implications for alcohol-related syncope. Circulation. 2000;101(4):398–402.PubMed — Alcohol Potentiates Orthostatic Hypotension 7. Demanet JC, Bonnyns M, Bleiberg H, Stevens-Rocmans C. Beer potomania: two cases and review of the literature. Clinical Nephrology. 1996.PubMed — Beer Potomania 8. Micoanski KS, Soriano JM, Gozalbo MM. Potomania and beer potomania: a systematic review of published case reports. Nutrients. 2025;17(12):2012.PubMed — Potomania and Beer Potomania Systematic Review 9. Corona G, Giuliani C, Parenti G, et al. Hyponatremia, falls and bone fractures: a systematic review and meta-analysis. Clinical Endocrinology. 2018;89(4):505–513.PubMed — Hyponatremia, Falls and Bone Fractures 10. Monnerat S, et al. Hyponatremia and aging-related diseases: key player or innocent bystander? A systematic review. 2023.PubMed — Hyponatremia and Aging-Related Diseases 11. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Annals of Pharmacotherapy. 2006;40(9):1618–1622.PubMed — SSRI-Associated Hyponatremia in Older Adults 12. Zhang Y, Zhang J, Jing R. Risk of antidepressant-induced hyponatremia in geriatric patients: a systematic review and meta-analysis. BMC Geriatrics. 2026.PubMed — Antidepressant-Induced Hyponatremia in Geriatric Patients 13. Woodward M, Gonski P, Grossmann M, Obeid J, Scholes R, Topliss DJ. Hyponatremia in older people: special considerations. Clinical Interventions in Aging. 2014;9:1987–1998.PubMed — Hyponatremia: Special Considerations in Older Patients The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog David S. Klein, MD FACA FACPM Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Extreme heat and prolonged sweating can cause significant water and sodium loss. Safe hydration requires recognizing when water is sufficient, when electrolyte replacement may be appropriate, and when symptoms require medical attention. Extreme heat brings familiar advice: Drink plenty of water. ******That is good advice—but it is incomplete. When you sweat, you do not lose water alone. You also lose sodium, chloride, and smaller quantities of other electrolytes. During prolonged gardening, hiking, exercise, yard work, or outdoor labor in summer heat, those losses can become substantial. There is an old lesson worth remembering: Water replaces water. Salt replaces salt. When you lose both, you may need to replace both. The challenge is knowing when ordinary food and water are sufficient, when deliberate electrolyte replacement makes sense, and when symptoms require medical attention. Quick Look Sweat contains both water and sodium. Sweat and sodium losses vary considerably between individuals. Several hours of heavy sweating can result in the loss of grams of sodium. Water alone cannot replace electrolytes lost in sweat. Normal meals usually provide adequate sodium during ordinary heat exposure. Hiking, exercise, gardening, landscaping, and outdoor work for several hours may require deliberate electrolyte replacement. Modern recommendations generally favor electrolyte beverages and salty foods over routine salt tablets. Drinking excessive amounts of plain water can cause dangerous hyponatremia. People with heart disease, kidney disease, hypertension, fluid restrictions, or certain medications should obtain individualized advice. Confusion, collapse, seizures, or altered mental status during heat exposure is an emergency. Sweat Is Not Just Water Sweating is one of our most important cooling mechanisms. As sweat evaporates from the skin, it removes body heat. but sweat contains salt. The sodium concentration of sweat varies widely according to genetics, heat acclimatization, diet, fitness, sweating rate, medications, and environmental conditions. Consider someone whose sweat contains approximately 1,000 mg of sodium per liter: Sweat Lost Approximate Sodium Lost Approximate Table-Salt Equivalent 1 liter 1,000 mg ~½ teaspoon 2 liters 2,000 mg ~¾–1 teaspoon 3 liters 3,000 mg ~1¼ teaspoons 4 liters 4,000 mg ~1¾ teaspoons 5 liters 5,000 mg ~2 teaspoons These figures are illustrations—not dosing instructions. Some people lose substantially less sodium, while particularly salty sweaters may lose considerably more. Over several hours, however, the cumulative loss can become important. Figure 1. How Much Salt Can You Lose Through Sweat? Prolonged heavy sweating during extreme heat, hiking, exercise, gardening, or outdoor work can result in substantial sodium loss. Sweat sodium concentrations vary considerably among individuals, making fluid and electrolyte replacement needs highly individualized. Gardening Counts as Exercise We readily associate dehydration with marathon runners and hikers. We often underestimate gardening and yard work. Digging, mowing, trimming trees, pushing a wheelbarrow, moving soil, landscaping, and working in direct sunlight can produce sustained sweating for hours. The same principle applies to: Hiking Running and walking Cycling Golf Tennis and pickleball Fishing and boating Construction Landscaping Agricultural work Outdoor home maintenance Someone can begin the morning adequately hydrated and several hours later be deficient in both water and sodium. Who Is Most at Risk? Anyone can develop heat illness, but risk increases among people who: Are over age 65 Are not acclimatized to heat Exercise or work outdoors for several hours Sweat heavily Have particularly salty sweat Take diuretics Have vomiting or diarrhea in addition to sweating Have cardiovascular or kidney disease Have diabetes Take medications affecting blood pressure, kidney function, sweating, or fluid balance Older adults deserve particular attention because thirst, cardiovascular responses, kidney function, and adaptation to heat may become less reliable with age. Whatever Happened to Salt Tablets? For generations, hikers, soldiers, athletes, farmers, and outdoor workers were taught to think about salt replacement during prolonged heat exposure. The underlying physiology was sound: Heavy sweating can produce substantial sodium loss. What has changed is how we replace it. Current occupational-health recommendations generally favor normal meals, salty foods, and balanced electrolyte beverages rather than routinely swallowing salt tablets. Concentrated salt tablets can cause nausea and vomiting and can provide inappropriate amounts of sodium for people with hypertension, kidney disease, heart failure, or prescribed sodium restrictions. But we should not discard the important lesson behind the old salt tablet. When someone is sweating heavily for hours, replacing water while completely ignoring sodium may also be a mistake. OSHA recommends electrolyte-containing beverages for people working in the heat for two hours or longer because water cannot replace the electrolytes being lost in sweat. The modern version of the old advice is therefore: Replace sodium when substantial sodium is actually being lost—and do it intelligently. Salt tablets may still have a role in an individualized plan for selected people engaged in prolonged strenuous activity, but they should not be considered a universal prescription for hot weather. Figure 2. Water Alone vs. Water + Electrolytes. Water is generally sufficient for short-duration or light activity, while prolonged heavy sweating during hiking, running, cycling, gardening, or outdoor work may require replacement of both fluids and sodium. The goal is to match hydration and electrolyte replacement to actual losses without overdrinking plain water. How Much Salt Do You Need? There is no single dose that is correct for everyone. Your requirement depends upon: Sweat rate × sweat sodium concentration × duration of activity. Ordinary heat exposure If you spend most of the day indoors, eat normally, and are not sweating heavily, additional salt is generally unnecessary simply because the temperature outside is high. An hour or two of sweating For most healthy people, water combined with normal meals and snacks is sufficient. Several hours of heavy sweating Now sodium replacement becomes increasingly relevant. Electrolyte-containing beverages and salty foods can help replace what is being lost. This becomes particularly important during prolonged hiking, strenuous exercise, gardening, landscaping, and outdoor labor. What about salt tablets? Do not think of salt tablets as a fixed dose that everyone should take. For someone who regularly undertakes prolonged strenuous activity in extreme heat, a planned sodium-replacement strategy can be developed according to anticipated sweat losses, diet, medical conditions, medications, and individual response. Clinical Pearl Don't Treat the Temperature. Replace What You Lose. Two people can spend the afternoon in 95°F weather and have completely different requirements. One is reading under a shaded porch. The other is digging and landscaping for four hours. The temperature is identical. Their physiologic losses are not. Duration + exertion + sweat rate + sweat sodium = actual loss. The Other Danger: Too Much Water There is an important counterpoint to dehydration: More water is not always better. Drinking excessive quantities of fluid during prolonged exercise can dilute serum sodium and contribute to exercise-associated hyponatremia. Symptoms may include: Headache Nausea Vomiting Weakness Bloating Confusion Abnormal behavior Seizures Loss of consciousness Severe exercise-associated hyponatremia can be life-threatening. This creates an important paradox: a confused hiker or athlete who has been drinking large quantities of water may not need more water. Heat exhaustion, heat stroke, dehydration, and hyponatremia can produce overlapping symptoms. Sodium supplementation does not make unlimited water consumption safe. See Figure 3: Heat Illness—Home Care, Call Your Doctor, or Emergency? Figure 3. Heat Illness: Know What to Do. A practical guide to recognizing heat-related symptoms and deciding when home care may be appropriate, when to contact your doctor, and when emergency treatment is necessary. Confusion, fainting, seizures, inability to walk normally, or rapidly worsening symptoms require immediate medical attention. When Can You Usually Manage It Yourself? An otherwise healthy person with mild thirst, fatigue, or cramping who remains fully alert and improves promptly after stopping activity can usually: Get out of the heat. Rest somewhere cool. Replace fluids gradually. Replace electrolytes if sweating has been prolonged. Eat a normal meal or salty snack. Avoid immediately returning to strenuous activity. The key is improvement. Salt loss during extreme heat is a tremendous health hazard. Symptoms that persist or worsen deserve greater attention. When Should You Call Your Doctor? Seek individualized medical advice if you have: Heart failure Chronic kidney disease Difficult-to-control hypertension A prescribed sodium restriction A fluid restriction Previous hyponatremia Recurrent heat illness Repeated dizziness or fainting Persistent muscle cramps Significant vomiting or diarrhea Diuretic treatment Multiple blood-pressure medications For these patients, deliberately increasing either water or sodium can have unintended consequences. When Is salt loss during extreme heat an Emergency? Confusion changes everything. Seek emergency medical assistance for: Confusion or abnormal behavior Collapse or loss of consciousness Seizures Severe difficulty walking Inability to drink Persistent vomiting Severe or rapidly worsening weakness Suspected heat stroke Do not assume an altered person simply needs more water—or more salt. Heat stroke requires rapid cooling and emergency medical care. What Your Doctor May Evaluate For recurrent or significant heat-related symptoms, your physician may consider: Blood pressure and orthostatic measurements Serum sodium Potassium and chloride Magnesium when appropriate Kidney function Glucose Medication effects Diuretic use Cardiovascular status Individual fluid and sodium requirements The goal is not merely to say, “Drink more water.” It is to determine what you lost, why you lost it, and why you became symptomatic. Continue Your Journey to Better Health Extreme heat affects more than hydration. Electrolyte balance, kidney function, blood pressure, cardiovascular health, and metabolism all influence how well the body tolerates prolonged sweating and physical activity. These related Stages of Life Medical Institute articles explore those connections in greater depth. What is a Mineral, and Why is it Essential? — The most direct companion article. It discusses sodium, potassium, chloride, and magnesium and specifically identifies excessive sweating and endurance exercise as causes of mineral deficiency. Magnesium Deficiency: The Most Common Mineral Deficiency. What Does it Do? — Particularly relevant to muscle cramps, cardiovascular stability, electrolyte balance, and patients taking diuretics. Creatine: Is It Safe for Everyone? Hidden Kidney Risks and Safer Alternatives — A strong connection to exercise, dehydration, kidney function, older adults, and medications that can reduce renal reserve. Pre-Diabetes: Insulin Resistance, Is It a Real Condition — Or a Warning Sign We Ignore at Our Own Risk? — Useful because metabolic dysfunction, diabetes, vascular health, and blood-pressure abnormalities can influence vulnerability during extreme heat. Uric Acid and Longevity: Live Longer by Keeping the Level below 5.5 mg/dl — Connects kidney physiology, vascular function, nitric oxide, blood pressure, and metabolic health to the broader discussion of heat stress. Frequently Asked Questions Should I take extra salt before gardening? Usually not for routine gardening. Prolonged vigorous gardening with heavy sweating is different and may justify planned electrolyte replacement. Is an electrolyte drink better than water? For short-duration activity, water is usually adequate. When heavy sweating continues for several hours, replacing electrolytes becomes increasingly important. Should hikers carry a source of salt? For prolonged hikes—particularly in extreme heat—carrying a source of sodium is sensible. This could include electrolyte powder, an electrolyte beverage, salty food, or, in an individualized replacement plan, measured sodium supplementation. Can I drink too much water? Yes. Excessive fluid intake can contribute to potentially life-threatening hyponatremia. What if I have high blood pressure? Do not assume that hypertension means you can never require sodium replacement. Conversely, do not assume heavy sweating gives you permission to consume unlimited salt. Your blood pressure, medications, kidney function, cardiovascular health, and degree of sweating all matter. The Bottom Line Our grandparents understood something important when they worried about salt loss in people working all day in the heat. The physiology has not changed. Heavy sweating means losing water and salt. During prolonged hiking, exercise, gardening, landscaping, or outdoor work, those losses can become substantial. What has changed is our ability to replace those losses more intelligently. For most people, normal meals, water, and—during prolonged heavy sweating—appropriately formulated electrolyte beverages are preferable to indiscriminate salt-tablet use. But the old lesson deserves to survive: When you sweat heavily for hours, water may not be enough. Water replaces water. Salt replaces salt. Sometimes you need both. Respect the heat. Replace what you lose. And recognize when the problem has progressed beyond something you should treat yourself. Continue Your Journey to Better Health Heat tolerance, electrolyte balance, blood pressure, kidney function, and metabolic health are interconnected. Continue exploring these related Stages of Life Medical Institute articles: Optimal Blood Pressure for Your Greatest Longevity What Is a Mineral, and Why Is It Essential? Magnesium Deficiency: The Most Common Mineral Deficiency. What Does It Do? Creatine: Is It Safe for Everyone? Hidden Kidney Risks and Safer Alternatives Pre-Diabetes: Insulin Resistance, Is It a Real Condition—or a Warning Sign We Ignore at Our Own Risk? Become a Patient If you repeatedly develop weakness, dizziness, muscle cramps, unusual fatigue, blood-pressure changes, or difficulty tolerating heat, simply drinking more water may not answer the question. At Stages of Life Medical Institute, we evaluate hydration and electrolyte balance in the larger context of kidney function, cardiovascular health, medications, metabolism, and overall physiology. References National Institute for Occupational Safety and Health. Criteria for a Recommended Standard: Occupational Exposure to Heat and Hot Environments. DHHS (NIOSH) Publication No. 2016-106. National Institute for Occupational Safety and Health. Heat Stress: Hydration. DHHS (NIOSH) Publication No. 2017-126. Occupational Safety and Health Administration. Heat—Water. Rest. Shade. U.S. Department of Labor. Occupational Safety and Health Administration. Keeping Workers Well-Hydrated. OSHA; 2026. Bennett BL, Hew-Butler T, Rosner MH, Myers T, Lipman GS. Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 Update. Wilderness Environ Med. 2020;31(1):50-62. PMID: 32044213. Hew-Butler T. Exercise-Associated Hyponatremia. Front Horm Res. 2019;52:178-189. PMID: 32097926. Hew-Butler T, et al. Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference. Clin J Sport Med. 2015. Sawka MN, et al. American College of Sports Medicine position stand: Exercise and fluid replacement. Med Sci Sports Exerc. Vrijens DMJ, Rehrer NJ. Sodium-free fluid ingestion decreases plasma sodium during exercise in the heat. J Appl Physiol. Anastasiou CA, et al. Sodium replacement and plasma sodium changes during exercise in the heat. J Athl Train. National Academies of Sciences, Engineering, and Medicine. Dietary Reference Intakes for Sodium and Potassium. Washington, DC: National Academies Press. Centers for Disease Control and Prevention. Heat and Older Adults (Aged 65+). Centers for Disease Control and Prevention. Heat and Medications—Guidance for Clinicians. Occupational Safety and Health Administration. Heat Stress Guide. U.S. Department of Labor. Wilderness Medical Society. Clinical Practice Guidelines for the Prevention and Treatment of Heat Illness. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Quick Look Can high uric acid cause high blood pressure? Higher uric acid is consistently associated with an increased risk of developing hypertension. Experimental research suggests that uric acid may contribute through oxidative stress, reduced nitric oxide, activation of the renin-angiotensin system, renal vasoconstriction, and altered sodium handling. However, association does not prove causation, and routinely lowering uric acid with medication has not been established as a standard treatment for hypertension. Uric acid is best known for causing gout, but its significance may extend well beyond painful joints. Higher uric acid levels are associated with hypertension, endothelial dysfunction, kidney disease, metabolic dysfunction, and cardiovascular risk. In a large analysis of prospective studies, every 1 mg/dL increase in serum uric acid was associated with approximately a 10% higher relative risk of developing hypertension.¹ The possible connection involves an intriguing network: ↑ Uric Acid → Oxidative Stress → ↓ Nitric Oxide + ↑ Renin-Angiotensin Activity → Renal Vasoconstriction → Altered Sodium Handling → Hypertension The kidneys may be central to this relationship because declining kidney function can also increase uric acid, potentially creating a feedback loop. What Is Uric Acid? Uric acid is the final product of purine metabolism in humans. Purines occur naturally within our cells and are also present in food. Most uric acid is removed through the kidneys, with additional elimination through the gastrointestinal tract. Levels can rise because the body produces more uric acid, eliminates less, or both. Common contributors include: reduced kidney function; insulin resistance; obesity and visceral fat; high fructose intake; alcohol consumption; certain purine-rich foods; dehydration; genetic differences in urate handling; and medications, particularly some diuretics. Many of these factors also increase the likelihood of hypertension. This raises an important question: Is uric acid simply a marker of metabolic dysfunction—or can it actually help drive high blood pressure? The evidence suggests that it may be both. Figure 1. Elevated uric acid may contribute to hypertension through oxidative stress, reduced nitric oxide availability, activation of the renin-angiotensin-aldosterone system (RAAS), vascular and renal vasoconstriction, impaired sodium excretion, and increased vascular resistance. Higher Uric Acid Predicts Future Hypertension Prospective studies consistently show that people with higher uric acid levels are more likely to develop hypertension. A meta-analysis of 17 prospective studies included more than 321,000 adults and nearly 66,000 new cases of hypertension. Every 1 mg/dL rise in serum uric acid was associated with roughly a 10% increase in relative hypertension risk.¹ That does not prove that uric acid directly causes hypertension, but several biological mechanisms make the relationship plausible. Uric Acid, Nitric Oxide, and Blood Vessels The inner lining of our blood vessels—the endothelium—plays an active role in regulating circulation. One of its most important signaling molecules is nitric oxide. Nitric oxide helps arteries relax and supports: vasodilation; normal vascular tone; tissue perfusion; and healthy blood-pressure regulation. Experimental evidence suggests that elevated intracellular uric acid can promote oxidative stress and reduce nitric oxide availability.²,⁵ Less nitric oxide means less ability for blood vessels to relax normally. The resulting pathway may be: ↑ Uric Acid → ↑ Oxidative Stress → ↓ Nitric Oxide → Vasoconstriction → ↑ Blood Pressure But the kidney may play an even larger role. Figure 2. Elevated uric acid, declining kidney function, sodium retention, and hypertension may form a self-reinforcing cycle. Reduced renal function can impair uric acid excretion, while hyperuricemia may contribute to oxidative stress, endothelial dysfunction, renal vascular injury, salt sensitivity, and higher blood pressure. The Kidney May Be the Critical Link The kidneys are among the body's most important long-term regulators of blood pressure. They determine how much sodium and water the body retains and participate in hormonal systems controlling vascular tone. Experimental hyperuricemia has been associated with: reduced nitric oxide activity; oxidative stress; activation of the renin-angiotensin system; renal vasoconstriction; and changes in renal sodium handling.²,⁶–⁸ Over time, these changes may contribute to injury of the kidney's small blood vessels and make blood pressure increasingly difficult to regulate. Uric Acid and Kidney Function: A Potential Vicious Cycle The relationship between uric acid and kidney function can operate in both directions. Because the kidneys eliminate much of the body's uric acid: ↓ Kidney Function → ↓ Urate Excretion → ↑ Uric Acid But experimental and observational evidence suggests that elevated uric acid may also participate in oxidative stress, endothelial dysfunction, renin-angiotensin activation, inflammation, and renal microvascular injury.²,⁵–⁹ This creates a potential cycle: ↓ Kidney Function → ↑ Uric Acid → Renal and Vascular Stress → Further ↓ Kidney Function That cycle may also affect sodium handling and contribute to hypertension. There is an important qualification, however. Large randomized clinical trials have not shown that lowering uric acid with allopurinol reliably slows kidney-function decline in patients with established chronic kidney disease or diabetic kidney disease.¹⁰,¹¹ So high uric acid should be viewed as an important risk marker and possible contributor, not proof that simply lowering the number will preserve kidney function. Clinical Pearl Uric acid may connect metabolism, blood vessels, kidneys, and blood pressure. A useful way to visualize the relationship is: ↑ Uric Acid → ↑ Oxidative Stress → ↓ Nitric Oxide + ↑ RAAS → Renal Vasoconstriction → Sodium Retention / Salt Sensitivity → Hypertension And because impaired renal function can raise uric acid: ↓ Kidney Function → ↑ Uric Acid The pathway can become a feedback loop. Figure 3. The proposed two-phase model of uric-acid-associated hypertension illustrates how early functional changes—including oxidative stress, reduced nitric oxide, RAAS activation, and renal vasoconstriction—may progress toward renal microvascular injury, impaired sodium excretion, salt sensitivity, and more established hypertension. The Two-Phase Model of Uric-Acid-Related Hypertension One particularly interesting hypothesis suggests that hypertension associated with hyperuricemia may evolve through two phases.²,⁶ Phase 1: Functional Hypertension Early elevations in uric acid may promote: reduced nitric oxide; oxidative stress; renin-angiotensin activation; renal vasoconstriction; and increased vascular resistance. At this stage, some of the abnormalities may still be relatively reversible. Phase 2: Salt-Sensitive Hypertension Persistent renal vascular stress may eventually produce structural changes in the kidney's microcirculation. The kidneys can then become less efficient at eliminating sodium at normal pressures. Hypertension becomes increasingly salt sensitive and may become less dependent upon the uric acid level that contributed earlier in the process. Conceptually: Hyperuricemia → Vasoconstriction → Renal Microvascular Injury → Impaired Sodium Excretion → Salt-Sensitive Hypertension What Happens When Uric Acid Is Lowered? A small randomized study of adolescents with newly diagnosed hypertension and elevated uric acid produced intriguing findings. When participants received allopurinol, uric acid fell substantially and 24-hour systolic blood pressure decreased by approximately 6 mmHg.⁴ That suggests uric acid may play a meaningful role in some patients—particularly younger people with early hypertension. But studies in adults with established disease have been considerably less convincing. This leads to an important principle: Association, causation, and treatment benefit are three different questions. Higher uric acid is clearly associated with hypertension. There are plausible biological pathways through which it could contribute. But routine pharmacologic lowering of uric acid has not been proven to be a standard treatment for hypertension. Relative Risk Versus Absolute Risk The approximately 10% increase in hypertension risk per 1 mg/dL increase in uric acid is a relative risk. Relative risk tells us how much risk changes proportionally. It does not tell us an individual's actual probability of developing hypertension. A 10% relative increase might raise a hypothetical risk from 5% to 5.5%. In someone whose baseline risk is 30%, the same relative increase would raise risk to 33%. That is why uric acid becomes particularly interesting when it occurs together with: insulin resistance + obesity + kidney dysfunction + hypertension + dyslipidemia + vascular disease The entire risk pattern matters more than any single laboratory value. What Level of Uric Acid Is Optimal? Traditional laboratory ranges are useful for identifying hyperuricemia and assessing gout risk. But the level associated with optimal metabolic and cardiovascular health may not necessarily be identical to the concentration at which urate crystals form. The critical level, or inflection point, would seem to be 5.4 to 5.5 mg/dl. Observational research associates increasing uric acid with hypertension and metabolic disease even across ranges that overlap conventional laboratory reference intervals. However, there is currently no universally accepted uric-acid treatment target for preventing hypertension in someone without gout or another established indication for urate-lowering therapy. What is known, however, is that longevity decreases as levels rise above 5.5 mg/dl. A laboratory value can therefore provide valuable information without automatically becoming a medication target. What Your Doctor May Evaluate When uric acid is elevated, the better question is often: Why is it elevated? Evaluation may include: uric acid trends; creatinine and eGFR; urinary albumin when appropriate; blood-pressure measurements; glucose and hemoglobin A1c; insulin resistance; triglycerides and HDL cholesterol; visceral adiposity; fructose intake; alcohol consumption; sodium intake; hydration; medication review; gout or kidney-stone history; and overall cardiovascular risk. Sometimes the most important finding is not the uric acid itself. It is the metabolic pattern surrounding it. Risk-Benefit Analysis: Should Every Elevated Uric Acid Be Treated? Elevations above 5.5 mg/dl are associated with increased cardiac risk and decreased longevity. Treatment at these levels would thereby provide benefit to the patient. It may not, however, decrease blood pressure primarily. A laboratory association does not automatically justify medication. For gout and certain other conditions, urate-lowering treatment has well-established indications. But treating asymptomatic hyperuricemia solely to lower blood pressure or prevent kidney decline is not currently established as routine therapy. Treatment decisions should weigh potential benefit against kidney function, gout history, stone disease, cardiovascular risk, medication adverse effects, interactions, and the strength of evidence that changing the uric acid level will improve the outcome being targeted. Frequently Asked Questions Can high uric acid cause high blood pressure? Possibly. Higher uric acid predicts future hypertension, and several mechanisms could explain a causal contribution. Whether serum uric acid independently causes hypertension in all patients remains unresolved. Can high uric acid affect the kidneys? Yes, although the relationship is complicated. High uric acid is associated with kidney disease, while reduced kidney function itself raises uric acid. Does lowering uric acid lower blood pressure? Sometimes, particularly in small studies involving younger patients with early hypertension. It has not been established as routine hypertension treatment. Should I take allopurinol because my uric acid and blood pressure are high? Not solely for that reason. Urate-lowering medication should be prescribed according to established clinical indications and the individual patient's complete medical situation. The Bottom Line Uric acid may tell us considerably more than whether someone is at risk for gout. Higher serum uric acid consistently predicts an increased likelihood of developing hypertension, and several biologically plausible pathways connect it with oxidative stress, impaired nitric oxide signaling, renin-angiotensin activation, renal vasoconstriction, abnormal sodium handling, and vascular dysfunction. The kidney may occupy the center of this relationship. ↑ Uric Acid ↔ ↓ Kidney Function → Sodium Retention / Salt Sensitivity → Hypertension But the distinction between association, causation, and successful treatment remains essential. For someone with elevated uric acid and hypertension, the most useful question may therefore not be: “How do we lower my uric acid?” It may be: “What metabolic, renal, vascular, or dietary process is causing my uric acid and blood pressure to rise together?” That question moves us beyond treating isolated numbers toward understanding the physiology producing them. Continue Your Journey to Better Health Uric acid, hypertension, endothelial function, kidney health, insulin resistance, and vascular aging are closely interconnected. Continue exploring these relationships with these Stages of Life Medical Institute articles: Uric Acid and Longevity: Live Longer by Keeping the Level below 5.5 mg/dl Uric Acid and Nitric Oxide: The Hidden Driver of Endothelial Dysfunction and Vascular Disease Optimal Blood Pressure for Your Greatest Longevity Insulin Resistance: The Hidden Precursor to Cardiovascular Disease, Dementia, and Accelerated Aging Pre-Diabetes: Insulin Resistance, Is It a Real Condition — Or a Warning Sign We Ignore at Our Own Risk? The Healing Power of Nourishment: Food as Medicine in Everyday Life Become a Patient At Stages of Life Medical Institute, we look beyond an isolated laboratory value or blood-pressure reading. A comprehensive evaluation considers how cardiovascular, metabolic, renal, hormonal, nutritional, and other physiologic systems interact. If you have concerns about elevated uric acid, hypertension, kidney function, insulin resistance, or cardiovascular risk, individualized evaluation can help determine what those numbers mean within the context of your overall health. References Wang J, et al. Dose-response association between serum uric acid levels and incident hypertension: a systematic review and meta-analysis of 17 prospective cohort studies. Acta Cardiol. 2021;76:748–757. Sanchez-Lozada LG, et al. Uric Acid and Hypertension: An Update With Recommendations. Am J Hypertens. 2020;33:583–594. Grayson PC, et al. Hyperuricemia and incident hypertension: systematic review and meta-analysis. Arthritis Care Res. 2011;63:102–110. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension. JAMA. 2008;300:924–932. Khosla UM, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739–1742. Mazzali M, et al. Elevated uric acid increases blood pressure by a novel crystal-independent mechanism. Hypertension. 2001;38:1101–1106. Mazzali M, et al. Hyperuricemia induces a primary renal arteriolopathy. Am J Physiol Renal Physiol. 2002;282–F997. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–1821. Johnson RJ, et al. Hyperuricemia, kidney disease, hypertension, and cardiovascular disease. Am J Kidney Dis. 2018. Badve SV, et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 2020;382:2504–2513. Doria A, et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med. 2020;382:2493–2503. Good medicine does not ask only whether a laboratory value is abnormal. It asks why it is abnormal, which physiologic systems are involved, how those systems interact, and whether changing the measurement itself has been shown to improve the patient's outcome. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Pulse pressure and stroke risk change with age as arterial stiffness increases and vascular physiology evolves. Understanding the age-dependent J-curve helps place systolic pressure, diastolic pressure, and pulse pressure into the context of individualized cardiovascular and stroke risk. Quick Look Most people know their blood pressure, but far fewer know their pulse pressure—the difference between the systolic and diastolic numbers, pulse pressure and stroke risk. A blood pressure of 120/80 mmHg has a pulse pressure of 40 mmHg. As we age, arteries generally become less elastic, systolic pressure tends to rise, and diastolic pressure may eventually plateau or fall. The resulting widening of pulse pressure can become an important marker of arterial stiffness and cardiovascular risk. The relationship is not as simple as “lower is always better.” Age, systolic pressure, diastolic pressure, arterial stiffness, medical conditions, medications, and overall cardiovascular risk all influence what a pulse pressure means for an individual patient. Figure 1. Pulse pressure is the difference between systolic and diastolic blood pressure. A reading of 120/80 mmHg produces a pulse pressure of 40 mmHg, reflecting the interaction between cardiac ejection and arterial elasticity. What Is Pulse Pressure? Every blood pressure measurement contains two numbers. Systolic blood pressure (SBP) is the peak arterial pressure generated when the heart contracts. Diastolic blood pressure (DBP) is the arterial pressure remaining while the heart relaxes between beats. Pulse pressure (PP) = Systolic blood pressure − Diastolic blood pressure For example: 120/80 mmHg → pulse pressure = 40 mmHg But pulse pressure is more than a mathematical subtraction. It reflects the interaction among stroke volume, the elasticity of the aorta and large arteries, pulse-wave transmission, and reflected pressure waves.¹,² When the aorta is young and compliant, it expands as blood is ejected from the heart and helps buffer the pressure wave. As arteries stiffen, they cannot absorb that energy as effectively. Systolic pressure rises, reflected waves return earlier, and pulse pressure tends to widen.¹–³ This is why pulse pressure can provide information about the cardiovascular system that is not immediately apparent from looking at either blood pressure number alone. Pulse Pressure Changes With Age Blood pressure does not age uniformly. During early and middle adulthood, systolic and diastolic pressures commonly rise together. Later in life, however, the pattern changes. Systolic pressure often continues to increase while diastolic pressure tends to plateau and may subsequently decline. The difference between them therefore becomes progressively wider.³,⁴ This widening is strongly related to aortic and large-artery stiffening. That means the same pulse pressure may have a different physiologic meaning at age 30 than at age 75. A relatively wide pulse pressure in a younger person may sometimes occur in the setting of a large stroke volume and relatively compliant arteries. In an older adult, particularly when accompanied by elevated systolic pressure and falling diastolic pressure, the same number is more likely to reflect vascular stiffening.³–⁵ Age therefore changes the context in which pulse pressure should be interpreted. Why Pulse Pressure Matters to the Brain The brain contains an enormous network of small blood vessels exposed continuously to the pulsatile energy generated by the heart. Healthy large arteries normally dampen some of this pulsatile energy before it reaches the microcirculation. With arterial stiffening, that protective buffering function becomes less effective. Greater pulsatile energy can therefore be transmitted downstream into smaller vessels.¹,² Over time, vascular aging and hypertension are associated with endothelial dysfunction, cerebral small-vessel disease, white-matter injury, and stroke. Studies of older populations have consequently found that widened pulse pressure predicts cardiovascular events—including stroke—beyond the information contained in conventional risk factors alone.⁵,⁶ Clinical Pearl Pulse pressure should not replace systolic or diastolic blood pressure. It adds another piece of information. A widening pulse pressure—especially when caused by rising systolic pressure combined with falling diastolic pressure—may be telling us something important about the aging arterial system. The J-Curve: Why Lower Is Not Always the Whole Story Blood-pressure risk is sometimes described using a J-shaped curve. At one end of the curve, excessive blood pressure clearly increases cardiovascular and stroke risk. Moving blood pressure downward generally reduces that risk. But observational studies have sometimes found increasing adverse outcomes again at very low pressures, producing the upward turn at the bottom of the “J.” The phenomenon has been particularly evident with low diastolic pressure and in people with established cardiovascular disease.⁷ There is an important qualification: modern evidence suggests that much of the apparent cardiovascular J-curve in observational studies may reflect reverse causation and residual confounding, rather than proving that intensive blood-pressure treatment itself causes cardiovascular events. Contemporary guidelines therefore continue to support effective blood-pressure reduction when treatment is tolerated.⁷ Nevertheless, very low pressures can produce clinically important problems such as orthostatic hypotension, syncope, falls, and renal injury, and extremely low on-treatment pressures have not been established as universally safe.⁷ The practical lesson is therefore not that physicians should fear lowering blood pressure. It is that blood pressure treatment must remain individualized. The J-Curve Changes With Age—or More Precisely, Its Clinical Meaning Does Figure 2. The clinical meaning of the blood pressure J-curve changes with age as arterial stiffness increases, systolic pressure tends to rise, diastolic pressure may fall, and pulse pressure widens. Individualized risk-benefit analysis balances cardiovascular and stroke prevention against the need to maintain adequate perfusion. This is where age becomes especially important. There is no scientifically validated table assigning every decade of life a single “ideal pulse pressure.” Nor should the J-curve be interpreted as a fixed mathematical curve that simply moves to a new predetermined value every ten years. Instead, the physiology surrounding the curve changes with aging. As people age: arteries generally become stiffer; systolic pressure becomes increasingly important as a predictor of cardiovascular events; diastolic pressure may fall; pulse pressure widens; vascular disease becomes more prevalent; and baseline absolute cardiovascular and stroke risk rises.³,⁴,⁸ Consequently, a pulse pressure of 60 mmHg does not necessarily carry the same clinical meaning in a healthy 35-year-old as it does in an 80-year-old with systolic hypertension, diabetes, chronic kidney disease, or known atherosclerosis. This distinction is central to understanding pulse pressure. Relative Risk Versus Absolute Risk Medical studies frequently describe relative risk. Suppose one group has a 20% higher relative risk of an event than another. That sounds substantial—but it does not tell us how likely the event actually is. If baseline risk were only 1%, a 20% relative increase would raise absolute risk to approximately 1.2%. If baseline risk were 20%, the same 20% relative increase would raise absolute risk to approximately 24%. The distinction becomes particularly important with aging. Research examining pulse pressure across the lifespan found an intriguing pattern: the relative risk associated with pulse pressure decreased with advancing age while the absolute risk increased substantially.⁸ That apparent paradox makes sense. Older people already have a higher baseline incidence of cardiovascular disease and stroke. Therefore, even a smaller proportional increase in risk can translate into a greater number of actual clinical events. For patients, absolute risk often provides the more useful perspective for making treatment decisions. Figure 3. Identical pulse pressures can represent very different cardiovascular and stroke risks. Age, systolic and diastolic blood pressure, arterial stiffness, comorbidities, and absolute cardiovascular risk determine the clinical significance of pulse pressure. Two Blood Pressures Can Have the Same Pulse Pressure—but Not the Same Meaning Consider: Blood Pressure Pulse Pressure 120/60 mmHg 60 mmHg 140/80 mmHg 60 mmHg 160/100 mmHg 60 mmHg All three have identical pulse pressures. They clearly do not represent identical cardiovascular physiology or identical clinical risk. Now consider an older patient with a pressure of 130/55 mmHg. The pulse pressure is 75 mmHg. The systolic pressure may initially appear reassuring, but the combination of a wide pulse pressure and relatively low diastolic pressure can suggest substantial arterial stiffness and deserves clinical context rather than interpretation from the systolic value alone.⁹ This is why pulse pressure should never be interpreted in isolation. Pulse Pressure and Stroke Risk Multiple observational studies have associated widened pulse pressure with increased cardiovascular risk, particularly in middle-aged and older populations.⁵,⁶,¹⁰ This does not mean that pulse pressure itself is necessarily the direct cause of every event. Pulse pressure can also function as a biomarker of the vascular environment in which stroke occurs: arterial stiffness, systolic hypertension, vascular aging, diabetes, kidney disease, smoking, and atherosclerosis frequently travel together. The clinical question is therefore broader than: “Is my pulse pressure too high?” A better question is: “Why is my pulse pressure widening, and what does it tell us about my overall vascular risk?” Risk-Benefit Analysis: Treat the Patient, Not the Subtraction Pulse pressure creates an important example of risk-benefit analysis in medicine. The potential benefit of blood-pressure treatment is substantial. Effective treatment of hypertension reduces cardiovascular events and stroke, and older patients can derive considerable absolute benefit because their baseline cardiovascular risk is higher.⁷ But treatment decisions must also consider possible harms: symptomatic hypotension, orthostatic symptoms, syncope, falls, renal effects, medication interactions, frailty, and individual tolerability. The objective is therefore not to chase a pulse-pressure number downward at all costs. Instead, treatment should address the underlying cardiovascular risk while preserving adequate pressure and functional well-being. That distinction becomes increasingly important as patients become older and medically more complex. That is the essence of individualized cardiovascular risk-benefit analysis. Continue Your Journey to Better Health Pulse pressure is only one window into cardiovascular health. Blood pressure, arterial stiffness, endothelial function, glucose regulation, inflammation, and metabolic health interact throughout life. Understanding these relationships helps move the focus beyond treating an isolated number toward identifying the physiologic factors that influence vascular health, stroke risk, and longevity. Explore these related articles from Stages of Life Medical Institute: Optimal Blood Pressure for Your Greatest Longevity — Learn why optimal blood pressure is more than a single number and how age, arterial stiffness, kidney function, medication effects, and treatment tolerance influence the balance between cardiovascular protection and excessively low pressure. Uric Acid and Longevity: Live Longer by Keeping the Level below 5.5 mg/dl — Explore the relationship among uric acid, nitric oxide, endothelial dysfunction, hypertension, vascular aging, cardiovascular risk, and longevity. Uric Acid and Nitric Oxide: The Hidden Driver of Endothelial Dysfunction and Vascular Disease — Discover how impaired nitric oxide availability may contribute to endothelial dysfunction, increased vascular tone, arterial stiffness, and hypertension. Insulin Resistance: The Hidden Precursor to Cardiovascular Disease, Dementia, and Accelerated Aging — Learn how insulin resistance and hyperinsulinemia can begin affecting vascular and neurologic health years before conventional glucose testing identifies diabetes. Pre-Diabetes: Insulin Resistance, Is It a Real Condition — Or a Warning Sign We Ignore at Our Own Risk? — Understand why metabolic and vascular injury can begin before diabetes develops and why early identification of insulin resistance may matter for long-term cardiovascular health. The Healing Power of Nourishment: Food as Medicine in Everyday Life — Explore how nutrition, omega-3 fatty acids, polyphenols, antioxidants, and other dietary components can influence inflammation, metabolic health, vascular function, and cardiovascular risk. These connections reinforce an important principle: cardiovascular risk is rarely determined by one measurement. Pulse pressure becomes most useful when interpreted within the patient's complete cardiovascular, vascular, metabolic, and clinical picture. Become a Patient At Stages of Life Medical Institute, we look beyond an isolated laboratory value or blood-pressure reading. Our approach considers how cardiovascular, metabolic, hormonal, renal, and other physiologic systems interact when evaluating an individual's long-term health. If you have concerns about blood pressure, cardiovascular risk, metabolic health, or healthy aging, a comprehensive medical evaluation can help place those numbers into the context that matters most: your individual health and risk profile. References Dart AM, Kingwell BA. Pulse pressure—a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001;37(4):975–984. Safar ME. Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension. Ther Adv Cardiovasc Dis. 2008;2(1):13–24. Franklin SS, Wong ND. Pulse pressure: how valuable as a diagnostic and therapeutic tool? J Am Coll Cardiol. 2016;67(4):404–406. McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912–4018. Swaminathan RV, Alexander KP. Pulse pressure and vascular risk in the elderly: associations and clinical implications. Am J Geriatr Cardiol. 2006;15:226–234. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354–360. McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912–4018. Staessen JA, et al. Relative and absolute risk to guide the management of pulse pressure, an age-related cardiovascular risk factor. Am J Hypertens. 2021;34(9):929–938. Spence JD. Risk from low blood pressure in frail older adults: diastolic pressure and pulse pressure are important. Age Ageing. 2021;50(6)–e6. Verdecchia P, et al. Pulse pressure and cardiovascular risk across clinical populations. Evidence from prospective cardiovascular studies. Good medicine does not treat numbers in isolation. A systems-based approach asks what produced the abnormal measurement, how it interacts with the rest of the patient's physiology, and which intervention offers the greatest long-term benefit with the least potential harm. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

When 'Normal' may not be "Normal" "The Longevity Pulse: What Your Resting Heart Rate Says About Your Health," featuring a healthy older adult checking a smartwatch displaying resting heart rate, alongside an anatomical heart illustration and ECG tracing to illustrate the relationship between resting heart rate, cardiovascular health, and longevity. Quick Look Every heartbeat tells a story. Long before blood pressure rises or cholesterol plaques become visible, subtle changes in your resting heart rate may reveal important clues about cardiovascular fitness, metabolic health, inflammation, stress, sleep quality, hormonal balance, and even longevity. Most physicians consider a resting heart rate between 60 and 100 beats per minute (bpm) to be normal. But normal does not necessarily mean optimal. Research involving hundreds of thousands of individuals has consistently shown that people with resting heart rates near the lower end of the normal range generally experience lower rates of cardiovascular disease, heart failure, stroke, and premature death than those with persistently elevated resting heart rates. Although no single number guarantees a long life, your resting pulse may be one of the most informative—and most overlooked—vital signs you can measure. Figure 1. Lifetime Heartbeats: Why a Few Beats Matter. Even modest differences in resting heart rate can translate into hundreds of millions of additional heartbeats over a lifetime. This infographic explains how resting heart rate reflects cardiovascular efficiency, autonomic balance, and overall health, making it an important biomarker for longevity and healthy aging. More Than Just a Number Most of us learned to check our pulse in elementary school. Today, smartwatches and fitness trackers monitor our heart rate around the clock, yet few people ask the most important question: What is my heart trying to tell me? Unlike cholesterol, which measures fat transport, or blood pressure, which measures the force inside your arteries, your resting heart rate reflects the combined influence of nearly every major organ system in your body. Your pulse is influenced by: · Cardiovascular fitness · Nervous system balance · Sleep quality · Body composition · Thyroid function · Blood sugar control · Chronic inflammation · Stress · Medications · Physical activity Very few health measurements provide so much information with so little effort. Figure 2. The Longevity Pulse Zone. This evidence-based infographic illustrates how resting heart rate relates to cardiovascular efficiency, autonomic nervous system balance, and long-term health. While the traditional "normal" range is 60–100 beats per minute, research suggests that a resting heart rate in the lower portion of the healthy range is often associated with better cardiovascular outcomes and increased longevity when interpreted in the context of an individual's age, fitness level, medications, and overall health. Your Heart Is an Efficiency Machine Imagine two automobiles traveling the same distance. One engine spends its life running at high RPMs. The other performs the same work while turning much more slowly. Both arrive at the destination, but one engine accomplishes the task with considerably less effort. Although the human body is far more sophisticated than an automobile, the principle is similar. A healthy cardiovascular system pumps more blood with each heartbeat. Because each contraction is more effective, the heart does not need to beat as frequently while at rest. The goal is not simply a slower pulse. The goal is greater cardiovascular efficiency. The Mathematics of a Lifetime A difference of only a few beats per minute may not seem important. In reality, it is remarkable. Consider two adults: Person A · Resting heart rate: 55 bpm Person B · Resting heart rate: 80 bpm Each day: · 55 bpm ≈ 79,000 heartbeats · 80 bpm ≈ 115,000 heartbeats That is more than 36,000 additional heartbeats every single day. Over one year, the difference approaches 13 million heartbeats. Over thirty years, the higher resting heart rate represents nearly 400 million additional heart contractions. This does not prove that one person will live longer than another. However, it illustrates why physiologists have long viewed resting heart rate as an important indicator of cardiovascular workload and efficiency. The Longevity Pulse Zone Perhaps the greatest misconception about resting heart rate is confusing normal with optimal. The traditional medical definition of “normal” is intended to identify dangerous abnormalities. Longevity medicine asks a different question: Where is health optimized? Resting Heart Rate Clinical Interpretation Less than 50 bpm Often normal in endurance athletes; may require evaluation in others 50–60 bpm Outstanding cardiovascular efficiency 60–70 bpm Excellent for most healthy adults 70–80 bpm Acceptable, but lifestyle improvements may provide additional benefit 80–90 bpm Associated with increasing cardiovascular and metabolic risk Greater than 90 bpm Persistent elevation deserves medical evaluation These ranges are general guidelines. Medications, athletic conditioning, thyroid disorders, and heart rhythm abnormalities must always be considered. Does Resting Heart Rate Change with Age? Surprisingly, not very much. Maximum heart rate declines steadily as we age, but resting heart rate remains relatively stable throughout adult life.What changes is the significance of an elevated pulse. A resting heart rate of 82 bpm in a healthy 30-year-old deserves attention. The same heart rate in a 75-year-old with hypertension, diabetes, obesity, and sleep apnea may represent substantially greater cardiovascular risk because the heart has less reserve and must function in the presence of multiple chronic conditions. In other words, resting heart rate changes little with age, but its importance increases dramatically as we grow older. Your Nervous System Controls Your Pulse Your heart does not decide how fast to beat. Your nervous system does. The sympathetic nervous system prepares your body for action by increasing heart rate. The parasympathetic nervous system, primarily through the vagus nerve, slows the heart and promotes recovery. Healthy adults generally have a better balance between these two systems, allowing the heart to remain calm and efficient while at rest. Regular aerobic exercise, restorative sleep, weight management, stress reduction, and good metabolic health all improve this balance naturally. Heart Rate Variability: The Next Vital Sign Resting heart rate tells us how fast the heart beats. Heart rate variability (HRV) tells us how adaptable the nervous system is. Individuals with higher HRV generally demonstrate better recovery, healthier autonomic balance, and greater resilience to physical and emotional stress. Many modern wearable devices now measure HRV automatically during sleep. Together, resting heart rate and HRV provide valuable insight into overall cardiovascular health. What Can Cause a High Resting Heart Rate? Persistently elevated resting heart rate is often the body’s way of asking for attention. Common contributors include: Cardiovascular · Hypertension · Coronary artery disease · Heart failure · Atrial fibrillation Metabolic · Obesity · Prediabetes · Diabetes · Insulin resistance Hormonal · Hyperthyroidism · Elevated cortisol · Menopause Lifestyle · Physical inactivity · Poor sleep · Obstructive sleep apnea · Chronic stress · Excess caffeine · Nicotine · Excess alcohol Medications · Thyroid hormone replacement · Stimulants · Some asthma medications · Certain decongestants Fortunately, many of these conditions are reversible or treatable. When a Slow Heart Rate Is Healthy—and When It Is Not. Resting Heart Rate and Longevity A slower pulse is often a sign of excellent cardiovascular fitness. However, not every slow heart rate is healthy. Healthy causes include: · Endurance training · Excellent aerobic conditioning · Strong vagal tone Potentially abnormal causes include: · Sick sinus syndrome · Heart block · Hypothyroidism · Medication effects · Certain neurologic disorders If a heart rate below 50 bpm is accompanied by dizziness, fainting, fatigue, or exercise intolerance, medical evaluation is appropriate. Can You Lower Your Resting Heart Rate? Absolutely—but the goal is not simply to lower the number. The real objective is to improve the health of the cardiovascular system so your heart no longer needs to work as hard. Effective strategies include: · Regular aerobic exercise · Resistance training · Weight reduction · Blood pressure optimization · Blood sugar control · Treatment of sleep apnea · Smoking cessation · Stress management · Better sleep habits · Treatment of thyroid disease · Limiting stimulant use when appropriate As your overall health improves, your resting heart rate often follows. What Does the Research Actually Show? Over the past three decades, numerous large population studies have reached a remarkably consistent conclusion: a higher resting heart rate is associated with an increased risk of cardiovascular disease, heart failure, stroke, and premature death—even after accounting for age, blood pressure, smoking, diabetes, and cholesterol levels.¹⁻⁴ Researchers believe this association reflects several overlapping mechanisms. A persistently elevated resting heart rate increases myocardial oxygen demand, shortens the time available for coronary artery filling during diastole, increases mechanical stress on arterial walls, and often signals chronic activation of the sympathetic ("fight-or-flight") nervous system.⁵⁻⁷ Several large meta-analyses have found that each 10-beat-per-minute increase in resting heart rate is associated with approximately a 9% to 16% increase in all-cause mortality and cardiovascular mortality, although the exact estimate varies among studies and patient populations.³⁻⁶ This does not mean that an increase from 60 to 70 beats per minute causes a 10% reduction in lifespan for a particular individual. Rather, resting heart rate functions as a powerful population-level biomarker that reflects the combined effects of fitness, autonomic function, inflammation, metabolic health, and cardiovascular reserve. For clinicians, resting heart rate has become an important "risk amplifier" that helps place traditional cardiovascular risk factors into a broader physiologic context. Figure 3. What Influences Your Resting Heart Rate? This systems-based infographic illustrates how resting heart rate is influenced by the interaction of cardiovascular fitness, autonomic nervous system balance, sleep quality, thyroid function, metabolic health, inflammation, body composition, stress, respiratory health, medications, and lifestyle habits. Rather than viewing heart rate as an isolated vital sign, it should be interpreted as a reflection of whole-body health and physiologic resilience. Medications Can Change the Story Not every resting heart rate should be interpreted the same way. Several commonly prescribed medications intentionally alter heart rate, meaning that the pulse must always be interpreted within the context of a patient's medical history. Medication Class Typical Effect on Resting Heart Rate Beta blockers Decrease heart rate Non-dihydropyridine calcium channel blockers Decrease heart rate Ivabradine Selectively decreases heart rate Thyroid hormone replacement May increase heart rate if dosage is excessive GLP-1 receptor agonists Mild increase in heart rate reported in some patients ADHD stimulant medications Often increase heart rate Asthma inhalers (beta-agonists) Temporary increase in heart rate Decongestants May increase heart rate This is one reason why patients should never compare their resting heart rate directly with someone else's without considering medications and underlying medical conditions. Clinical Pearl At Stages of Life Medical Institute, we view resting heart rate as far more than another vital sign. We interpret it alongside blood pressure, ApoB, lipoprotein(a), HbA1c, hs-CRP, thyroid function, body composition, sleep quality, medication use, and cardiorespiratory fitness to better understand your overall health and identify opportunities to improve longevity. Your Resting Heart Rate Report Card Resting Heart Rate What It May Mean Suggested Next Step 56 bpm Excellent cardiovascular efficiency Maintain healthy lifestyle 66 bpm Very good Continue current habits 74 bpm Good Increase aerobic conditioning 82 bpm Elevated Evaluate weight, sleep, blood pressure, and metabolic health 92 bpm High Discuss with your healthcare provider Remember that these are general educational guidelines and should always be interpreted within the context of your overall health, medications, and physical conditioning. Frequently Asked Questions Is a resting heart rate of 85 bpm normal? It falls within the traditional “normal” range, but research suggests that persistently resting in the mid-80s may be associated with higher long-term cardiovascular risk than resting in the 50s or 60s. Should everyone try to have a heart rate of 55 bpm? No. Healthy targets depend on age, medications, athletic conditioning, and medical history. The goal is a healthy cardiovascular system—not simply a lower number. Are smartwatch heart rate measurements accurate? Most modern wearable devices provide reliable resting heart rate estimates, particularly when measurements are averaged overnight. Can stress really increase resting heart rate? Yes. Chronic stress activates the sympathetic nervous system, often producing a persistently higher resting pulse. Bottom Line Your resting heart rate is one of the simplest health measurements you can obtain, yet it offers remarkable insight into your cardiovascular fitness, metabolic health, autonomic nervous system balance, and long-term health. Rather than asking whether your pulse is merely “normal,” consider whether it reflects the healthiest version of you. Improving your fitness, sleep, nutrition, weight, and metabolic health often benefits your resting heart rate—and those same changes are among the most effective ways to increase both lifespan and healthspan. Continue Your Journey to Better Health Understanding your resting heart rate is just one step toward better cardiovascular health. You may also enjoy these related topics from the Stages of Life Medical Institute: · Prediabetes: Why an HbA1c Above 5.5% Matters · Uric Acid and Longevity · Quercetin and Metabolic Health · DHA: Beyond Heart Health · Low-Dose Lithium and Healthy Aging · Adrenal Function and Chronic Stress The following references represent the strongest evidence base for the article and provide a balance of landmark epidemiologic studies, systematic reviews, and contemporary guideline perspectives. References Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50:823-830. Cooney MT, Vartiainen E, Laakitainen T, et al. Elevated resting heart rate is an independent risk factor for cardiovascular disease. Am Heart J. 2010;159:612-619. Zhang D, Shen X, Qi X. Resting heart rate and all-cause and cardiovascular mortality: a meta-analysis. CMAJ. 2016;188:E53-E63. Böhm M, Schumacher H, Teo KK, et al. Resting heart rate and cardiovascular outcomes in the general population. Lancet. 2010. Palatini P. Elevated heart rate as a cardiovascular risk factor. Prog Cardiovasc Dis. 2009. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate. Eur Heart J. 2005. American Heart Association. Target Heart Rates and Exercise Guidelines. American College of Cardiology/American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease. European Society of Cardiology Guidelines for Cardiovascular Disease Prevention. Harvard Medical School. Resting Heart Rate and Longevity (patient education review). Become a Patient At Stages of Life Medical Institute, we believe exceptional medical care begins with understanding why the body functions the way it does. Through comprehensive cardiovascular risk assessment, advanced laboratory testing, metabolic evaluation, hormone optimization, nutrition, and personalized lifestyle strategies, we help our patients pursue healthier aging and a longer, more active life. Our philosophy is straightforward: rather than treating symptoms or laboratory values in isolation, we identify and address the underlying physiologic processes that influence long-term health, resilience, and longevity. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

By David S. Klein, MD Stages of Life Medical Institute Figure – Title Slide. C15:0 (Pentadecanoic Acid): Could This Be the First Newly Recognized Essential Fatty Acid in Nearly 100 Years? This introduction highlights the emerging science of C15:0, an odd-chain saturated fatty acid naturally found in dairy foods that is being investigated for its potential role in cellular health, metabolic function, and healthy aging. Quick Look For nearly a century, only two fatty acids have been universally recognized as essential to human health. Emerging research now suggests that pentadecanoic acid (C15:0)—an odd-chain saturated fatty acid found naturally in dairy fat—may possess unique biological properties that distinguish it from other saturated fats. While scientists have not yet confirmed C15:0 as an essential fatty acid, early evidence suggests it may support healthy cell membranes, mitochondrial function, metabolic health, and healthy aging. This article reviews what we know, what remains uncertain, and how C15:0 may fit into an overall healthy lifestyle. A New Way of Thinking About Saturated Fat For many years, saturated fat was discussed as though it represented a single nutrient with uniform effects on human health. Modern nutritional science has shown that this is an oversimplification. Individual saturated fatty acids differ in structure, metabolism, and biological activity. One of the most intriguing examples is C15:0 (pentadecanoic acid), a naturally occurring odd-chain saturated fatty acid found primarily in the milk fat of cows, sheep, and goats. Unlike the more common even-chain saturated fatty acids, C15:0 appears to behave differently within the body and has become the focus of growing scientific interest. Researchers first noticed that people with higher circulating blood levels of C15:0 consistently experienced lower rates of insulin resistance, type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and some cardiovascular outcomes. Although these observations do not prove cause and effect, they prompted investigators to explore whether C15:0 itself might contribute to better health rather than simply serving as a marker of dairy consumption. Figure 2. C15:0 (pentadecanoic acid) supports multiple biological pathways involved in metabolic health, including mitochondrial function, membrane stability, insulin signaling, inflammation control, and liver health. Emerging clinical evidence suggests improvements in insulin sensitivity, inflammatory biomarkers, lipid metabolism, and healthy aging, while natural dietary sources include full-fat dairy products from grass-fed animals. What Makes C15:0 Different? C15:0 belongs to a small family of odd-chain fatty acids, the two most common being C15:0 and C17:0. Although these molecules appear similar, current evidence suggests they are not biologically identical. C15:0 appears to depend largely on dietary intake, whereas C17:0 can be produced to some extent by the body. Laboratory studies also suggest that C15:0 has broader biological activity, including effects on cell membrane stability, mitochondrial function, inflammatory signaling, and metabolic regulation. These findings have led some investigators to propose that C15:0 may satisfy several characteristics of an essential fatty acid, although further human studies are required before that conclusion can be reached. How Might C15:0 Support Health? Experimental studies suggest several potential mechanisms: Healthy cell membranes: C15:0 becomes incorporated into cell membranes, helping maintain their structural integrity and function. Mitochondrial support: Healthy mitochondria are essential for efficient energy production. Early studies suggest C15:0 may help maintain mitochondrial performance under metabolic stress. Metabolic regulation: C15:0 appears to influence cellular pathways involved in lipid metabolism and insulin sensitivity. Inflammation: Laboratory models suggest C15:0 may reduce several inflammatory signaling pathways. Cellular resilience: Researchers are studying whether C15:0 helps protect cells against ferroptosis, an iron-dependent form of cell injury increasingly linked to aging and chronic disease. These laboratory findings are encouraging, but additional human studies are needed to determine how these mechanisms translate into clinical outcomes. Figure 3. Emerging evidence suggests that C15:0 (pentadecanoic acid) may influence multiple biological systems involved in healthy aging, including metabolic regulation, mitochondrial function, liver health, membrane integrity, inflammation control, cardiovascular health, and cognitive resilience. This infographic summarizes current clinical findings, dietary sources, supplement considerations, and the potential role of C15:0 in preventive and longevity-focused medicine. What Does the Clinical Evidence Show? Several large observational studies have reported that individuals with higher circulating C15:0 concentrations tend to have: Better insulin sensitivity Lower risk of developing type 2 diabetes Lower rates of metabolic dysfunction-associated steatotic liver disease (MASLD) More favorable lipid profiles Lower rates of certain cardiovascular events Because these studies are observational, they cannot prove that C15:0 directly causes these benefits. People with higher C15:0 levels may also have healthier dietary patterns or lifestyles. Nevertheless, the consistency of these findings across multiple populations has made C15:0 one of the more intriguing areas of nutritional research. Where Is C15:0 Found? Natural dietary sources include: Food Relative C15:0 Content Aged cheddar High Parmesan High Gouda High Gruyère High Blue cheese High Grass-fed butter Very High Whole-fat yogurt Moderate Whole milk Moderate Lamb Moderate Beef Lower Grass-fed dairy products generally contain somewhat higher concentrations of C15:0 than conventionally produced dairy, although both contribute meaningful amounts. How Much Do You Need? There is currently no Recommended Dietary Allowance (RDA), Adequate Intake (AI), or Daily Value (DV) for C15:0. Typical Western diets appear to provide approximately 50–100 mg per day, while diets richer in full-fat dairy often provide 100–200 mg daily. Some researchers have suggested that 100–300 mg per day may reproduce blood concentrations associated with favorable metabolic outcomes in observational studies. These values should be viewed as research-based estimates rather than official recommendations. For most people who consume dairy, obtaining C15:0 through whole foods remains the preferred approach. Should You Take a Supplement? Purified C15:0 supplements have recently entered the marketplace. While the science is promising, no major medical organization currently recommends routine supplementation for the prevention or treatment of chronic disease. If you avoid dairy because of allergy, intolerance, or dietary preference, supplementation may eventually prove beneficial, but additional clinical trials are needed before firm recommendations can be made. Clinical Pearl Nutrition science continues to evolve. Rather than viewing all saturated fats as identical, researchers increasingly recognize that individual fatty acids have unique biological functions. C15:0 is an excellent example of how advances in lipid science are reshaping our understanding of nutrition. What I Tell My Patients "The research on C15:0 is genuinely exciting, but it is still emerging. I encourage patients to focus first on an overall healthy dietary pattern rather than a single nutrient. If you enjoy dairy and have no medical reason to avoid it, moderate amounts of fermented dairy products such as yogurt and aged cheeses may provide naturally occurring C15:0 along with many other beneficial nutrients. As stronger clinical evidence becomes available, our recommendations will continue to evolve." Frequently Asked Questions Is C15:0 the same as omega-3? No. C15:0 is an odd-chain saturated fatty acid with different biological properties. Should everyone take a C15:0 supplement? Not at this time. Whole-food sources are preferred while additional clinical evidence accumulates. Does this mean all saturated fat is healthy? No. Individual saturated fatty acids differ biologically. The emerging evidence regarding C15:0 should not be generalized to all saturated fats. Bottom Line C15:0 represents one of the most promising developments in modern nutritional science. Although more research is needed before definitive recommendations can be made, current evidence suggests that this naturally occurring odd-chain fatty acid may support metabolic health and healthy aging. Until additional clinical trials are completed, the most practical approach is to emphasize an overall healthy dietary pattern that includes nutrient-rich whole foods, while discussing individualized dietary choices with your physician. Continue Your Journey to Better Health You may also enjoy our articles on: Low-Dose Lithium and Brain Health Alpha-Lipoic Acid and Mitochondrial Health Quercetin and Metabolic Health Hashimoto's Thyroiditis Adrenal Function and Whole-Body Health References Venn-Watson S, Lumpkin R, Dennis EA. Efficacy and safety of C15:0 supplementation in improving metabolic health: a randomized clinical trial. Nutrients. 2024;16. Available from: https://pubmed.ncbi.nlm.nih.gov/ Venn-Watson S, Lumpkin R, Dennis EA. Pentadecanoic acid is an emerging essential fatty acid. Nutrients. 2020;12(10):2876. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600519/ Venn-Watson S, Lumpkin R. The rediscovery of C15:0 as an essential fatty acid. Front Nutr. 2022. Available from: https://pubmed.ncbi.nlm.nih.gov/ Houts J, Venn-Watson S, et al. Pentadecanoic acid supplementation improves metabolic markers in adults with metabolic syndrome. Nutrients. 2023. Available from: https://pubmed.ncbi.nlm.nih.gov/ Venn-Watson S, Lumpkin R, Dennis EA. Odd-chain saturated fatty acids and healthy aging. Frontiers in Nutrition. 2021. Available from: https://www.frontiersin.org/ Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2:810–818. https://pubmed.ncbi.nlm.nih.gov/24795240/ Imamura F, Fretts A, Marklund M, et al. Fatty acid biomarkers of dairy fat consumption and incident cardiovascular disease. PLoS Med. 2018;15:e1002670. https://pubmed.ncbi.nlm.nih.gov/30408074/ de Oliveira Otto MC, Nettleton JA, Lemaitre RN, et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease. Am J Clin Nutr. 2018. https://pubmed.ncbi.nlm.nih.gov/ Yakoob MY, Shi P, Willett WC, et al. Circulating biomarkers of dairy fat and coronary heart disease risk. Circulation. 2014. https://pubmed.ncbi.nlm.nih.gov/ Marklund M, Wu JHY, Imamura F, et al. Biomarkers of dairy fat and incident diabetes: pooled cohort analysis. PLoS Med. 2018. https://pubmed.ncbi.nlm.nih.gov/ Wu JHY, Lemaitre RN, Imamura F, et al. Odd-chain saturated fatty acids and cardiometabolic disease risk. Circulation. 2017. https://pubmed.ncbi.nlm.nih.gov/ Mozaffarian D. Dairy foods, saturated fat, and cardiometabolic health. Circulation. 2016. https://pubmed.ncbi.nlm.nih.gov/ Astrup A, Magkos F, Bier DM, et al. Saturated fats and health: a reassessment. J Am Coll Cardiol. 2020;76:844–857. https://pubmed.ncbi.nlm.nih.gov/32762925/ Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355–374. https://pubmed.ncbi.nlm.nih.gov/22254027/ Dennis EA, Norris PC. Eicosanoid storm in inflammation and its resolution. Nat Rev Immunol. 2015;15:511–523. https://pubmed.ncbi.nlm.nih.gov/26228773/ Jump DB. Fatty acid regulation of metabolism. Physiol Rev. 2008;88:775–827. https://pubmed.ncbi.nlm.nih.gov/18391172/ National Institutes of Health Office of Dietary Supplements. Dietary Fats Fact Sheet for Health Professionals. https://ods.od.nih.gov/ Harvard T.H. Chan School of Public Health. The Nutrition Source: Fats and Cholesterol. https://www.hsph.harvard.edu/nutritionsource/ American Heart Association. Dietary Fats. https://www.heart.org/ U.S. Department of Agriculture. FoodData Central. https://fdc.nal.usda.gov/ Become a Patient At Stages of Life Medical Institute, we believe that lasting wellness begins by identifying and treating the root causes of disease. Our comprehensive evaluations integrate advanced laboratory testing, evidence-based nutrition, hormone optimization when appropriate, and personalized treatment plans designed to support lifelong health. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com Publication Version 1.0 • © 2026 Stages of Life Medical Institute. All rights reserved.

Pepto-Bismol® (bismuth subsalicylate) is one of the most extensively studied over-the-counter gastrointestinal medications. This physician-authored educational overview introduces its evidence-based role in functional dyspepsia, prevention and treatment of uncomplicated traveler's diarrhea, selected foodborne illnesses, and Helicobacter pylori eradication therapy. Despite more than a century of clinical use, it remains an underappreciated therapeutic option in modern digestive health and travel medicine. Quick Look Pepto-Bismol® (bismuth subsalicylate) is one of the most extensively studied over-the-counter gastrointestinal medications. It remains useful for functional dyspepsia, symptomatic treatment of uncomplicated infectious diarrhea, prevention of many cases of traveler's diarrhea, and as a component of Helicobacter pylori eradication therapy. More Than a Remedy for an Upset Stomach Few over-the-counter medications have remained in continuous clinical use for more than a century while continuing to earn a place in modern evidence-based medicine. Although many people think of Pepto-Bismol simply as the 'pink medicine' for an upset stomach, its active ingredient—bismuth subsalicylate—possesses antimicrobial, anti-inflammatory, antisecretory, toxin-binding, and mucosal protective properties that continue to be supported by modern clinical research. Functional Dyspepsia (Formerly Referred to as Cryptogenic Dyspepsia) Dyspepsia is one of the most common gastrointestinal complaints. When upper endoscopy and other diagnostic testing fail to identify a structural explanation, the condition is referred to as functional dyspepsia. Symptoms commonly include upper abdominal discomfort, early satiety, bloating, nausea, belching, and post-prandial fullness. Current evidence suggests that altered gastric motility, visceral hypersensitivity, low-grade inflammation, and changes in the gut microbiome all contribute. Why Pepto-Bismol® Can Help Bismuth subsalicylate addresses several of these mechanisms simultaneously by coating the gastric mucosa, reducing local inflammation, binding bile acids and bacterial toxins, and exerting direct antimicrobial activity against several enteric pathogens. These complementary actions make it a useful option for selected patients with mild to moderate functional dyspepsia. Traveler's Diarrhea Traveler's diarrhea remains one of the most common illnesses affecting international travelers. Most cases are caused by enterotoxigenic Escherichia coli, Campylobacter, Shigella, or Salmonella. For uncomplicated illness, hydration and supportive care are often sufficient, and unnecessary antibiotic use should be avoided whenever appropriate. Prevention of Traveler's Diarrhea Multiple randomized clinical trials have shown that prophylactic bismuth subsalicylate can substantially reduce the incidence of traveler's diarrhea when used appropriately. It should complement—not replace—careful food and water precautions. A Practical Tip from My Air Force Experience During my service as a U.S. Air Force flight surgeon, overseas travel and brief deployments were a routine part of military medicine. Traveler's diarrhea could impair operational readiness, making prevention just as important as treatment. Rather than carrying the familiar liquid formulation of Pepto-Bismol®, I routinely packed the chewable tablets. They are compact, lightweight, easy to carry, and avoid the inconvenience of traveling with liquids. My personal routine was simple: before eating or drinking anything—including meals, snacks, coffee, bottled water, soft drinks, or other beverages—I would chew one Pepto-Bismol® tablet. The objective was to have the medication present before potential exposure to food- or water-borne pathogens rather than waiting until symptoms developed. Over years of international travel, I found this to be a practical strategy that complemented careful food and water choices. Although no preventive measure can completely eliminate the risk of traveler's diarrhea, the chewable tablets made consistent use easy. Even today, whenever I travel internationally, Pepto-Bismol® tablets remain one of the first items I pack. This reflects my personal travel routine and should not replace individualized medical advice. Travelers should consult their healthcare professional before using bismuth subsalicylate if they have contraindications such as aspirin allergy, active gastrointestinal bleeding, significant kidney disease, pregnancy, or concurrent anticoagulant therapy. Foodborne Illness Foodborne illness affects millions of people each year and ranges from mild, self-limited gastrointestinal upset to severe infection. Bismuth subsalicylate can provide meaningful symptomatic relief for many uncomplicated illnesses through toxin binding, antimicrobial activity, anti-inflammatory effects, and reduction of intestinal fluid secretion. Patients with high fever, bloody diarrhea, severe abdominal pain, dehydration, or prolonged symptoms should seek prompt medical evaluation. An Old Medication with a Modern Role: Helicobacter pylori Bismuth remains a key component of bismuth quadruple therapy for Helicobacter pylori infection. Research demonstrates that it disrupts bacterial cell walls, interferes with bacterial enzymes, reduces bacterial adherence, and enhances companion antibiotics. Why Antibiotic Stewardship Matters Many uncomplicated gastrointestinal illnesses improve with hydration and supportive care. Judicious use of bismuth subsalicylate may reduce unnecessary antibiotic exposure while preserving antibiotics for patients who truly need them. Clinical Pearl Pepto-bismol for Traveler's Diarrhea: During more than four decades of practice, dating back to my service as a U.S. Air Force flight surgeon, I have found that prompt hydration combined with early use of bismuth subsalicylate often provides excellent symptom control for uncomplicated travel-related gastrointestinal illness. Frequently Asked Questions • Black stool or tongue: A harmless temporary effect. • Daily use: Persistent symptoms deserve medical evaluation. • Traveler's diarrhea: Clinical studies support prophylactic use in appropriate adults. • Children: Avoid in children recovering from viral illness because of the risk of Reye syndrome. • Contraindications: Aspirin allergy, pregnancy, active GI bleeding, anticoagulant therapy, and significant kidney disease require medical guidance. Figure 3. This comprehensive patient guide summarizes the evidence-based clinical uses of Pepto-Bismol® (bismuth subsalicylate) for functional dyspepsia, prevention and treatment of uncomplicated traveler's diarrhea, selected foodborne illnesses, and as an adjunct in Helicobacter pylori therapy. The infographic also highlights practical travel medicine recommendations, medication safety precautions, common adverse effects, warning signs that require medical evaluation, and key clinical take-home points to help patients use this medication safely and effectively. What Your Doctor May Evaluate Persistent symptoms may warrant evaluation for Helicobacter pylori infection, peptic ulcer disease, gallbladder disease, inflammatory bowel disease, celiac disease, medication-related gastritis, or other gastrointestinal disorders. Bottom Line Pepto-Bismol® remains one of the most versatile over-the-counter gastrointestinal medications available. Supported by more than a century of clinical experience and decades of scientific investigation, it continues to have an important place in evidence-based digestive health. Down to Basics 120 capsules. Take 2 twice daily. 1 month supply for $29.99 Continue Your Journey to Better Health Explore related SOLMI articles on the gut microbiome, probiotics, berberine, alpha-lipoic acid, lactoferrin, and quercetin. Become a Patient At Stages of Life Medical Institute, our goal is to identify and treat the underlying causes of illness using an evidence-based, personalized approach. Our Philosophy Symptoms rarely occur in isolation. Lasting health is achieved by understanding how organ systems interact and by treating the root causes of disease rather than simply suppressing symptoms. References 1. Moayyedi PM, et al. ACG/CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. PubMed: https://pubmed.ncbi.nlm.nih.gov/28631728/ 2. Talley NJ, Ford AC. Functional Dyspepsia. N Engl J Med. PubMed: https://pubmed.ncbi.nlm.nih.gov/26535514/ 3. DuPont HL. Prevention of Travellers' Diarrhoea. Aliment Pharmacol Ther. PubMed: https://pubmed.ncbi.nlm.nih.gov/18248659/ 4. CDC Yellow Book. Travelers' Diarrhea. 5. Chey WD, et al. ACG Guideline: Helicobacter pylori. 6. Maastricht VI/Florence Consensus Report. 7. Guerrant RL, et al. Infectious Diarrhea Guidelines. 8. Ericsson CD. Travellers' diarrhoea. 9. Graham DY. Bismuth therapy. 10. FDA Pepto-Bismol labeling. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Low-Dose Lithium: Neuroprotection, Brain Health, and Longevity. Title illustration introducing the emerging evidence supporting micro-dose lithium for cognitive health, neuroprotection, healthy aging, and longevity. Professional medical infographic by Stages of Life Medical Institute. Quick Look Depression affects more than 280 million people worldwide and remains one of the leading causes of disability. While conventional antidepressants are effective for many individuals, nearly one-third of patients fail to achieve complete remission, and others experience unwanted side effects or incomplete symptom control.¹ In recent years, growing scientific interest has focused on an unexpected therapeutic option: low-dose lithium. Although lithium has been prescribed for more than 75 years as a treatment for bipolar disorder, modern research suggests that much lower doses may exert unique biological effects on the brain. Laboratory and clinical studies indicate that lithium influences neuroplasticity, reduces neuroinflammation, supports mitochondrial function, increases brain-derived neurotrophic factor (BDNF), and inhibits glycogen synthase kinase-3 beta (GSK-3β)—a key enzyme implicated in depression, Alzheimer's disease, and accelerated brain aging.²–⁶ At Stages of Life Medical Institute, we view depression through a systems-based lens. Rather than asking only which medication may improve symptoms, we seek to understand why symptoms developed in the first place. Nutritional deficiencies, insulin resistance, thyroid dysfunction, chronic inflammation, hormonal imbalance, sleep disorders, and mitochondrial dysfunction frequently coexist with depression and may contribute to its severity. Identifying and addressing these factors remains an essential component of personalized care. Key Takeaways for Patients Lithium is far more than a medication for bipolar disorder. At lower doses, it may provide neuroprotective and mood-supporting benefits in selected patients. Depression is often multifactorial. Thyroid disease, insulin resistance, chronic inflammation, nutrient deficiencies, poor sleep, and hormonal imbalance should all be considered during evaluation. Emerging research suggests that low-dose lithium may enhance neuroplasticity, reduce inflammation, and protect brain cells, potentially improving both mood and long-term cognitive health. Lithium should never be self-prescribed. Even low doses require physician guidance to determine whether treatment is appropriate and to monitor safety. Lifestyle remains fundamental. Regular exercise, restorative sleep, stress reduction, proper nutrition, and correction of underlying metabolic abnormalities remain essential components of depression treatment. The goal is not simply symptom relief—it is restoring healthy brain function. Depression: More Than a Chemical Imbalance For decades, depression was commonly explained as a deficiency of serotonin or other neurotransmitters. While neurotransmitters certainly play an important role, this explanation is now recognized as overly simplistic. Depression represents a complex interaction among genetics, environmental influences, immune activation, endocrine function, metabolism, mitochondrial health, and neuroplasticity.⁷ Modern neuroscience demonstrates that depression is associated with measurable structural and functional changes within the brain. Chronic stress, systemic inflammation, oxidative stress, insulin resistance, and elevated cortisol may impair communication between neurons, reduce synaptic density, and shrink critical brain regions such as the hippocampus. These changes contribute not only to depressed mood but also to impaired concentration, reduced motivation, memory difficulties, and emotional resilience.⁸ Rather than focusing exclusively on increasing neurotransmitter levels, many investigators now seek therapies capable of restoring normal neuronal function and promoting the brain's remarkable capacity to repair itself. This process, known as neuroplasticity, has become one of the central concepts in contemporary depression research. Figure 2. Clinical Benefits of Low-Dose Lithium for Brain Health and Longevity. Medical infographic summarizing the emerging evidence linking micro-dose lithium with cognitive resilience, neuroprotection, mood stability, mitochondrial health, reduced neuroinflammation, and healthy aging across the lifespan. Professional medical infographic from Stages of Life Medical Institute. What Is Lithium? Lithium is a naturally occurring trace mineral found in soil, groundwater, and small amounts in many foods. Unlike antidepressants, lithium does not act primarily by increasing serotonin or dopamine concentrations. Instead, it functions as a cellular signaling molecule, influencing dozens of intracellular pathways involved in neuronal survival, inflammation, oxidative stress, and synaptic communication.⁹ Since the late 1940s, lithium carbonate has been considered one of the most effective treatments for bipolar disorder and remains the only psychiatric medication consistently shown to reduce suicide risk.¹⁰ However, the doses used for bipolar disorder produce blood concentrations that require regular laboratory monitoring because of the potential for kidney and thyroid effects. Lithium Orotate 10 mg per capsule. 60 capsules Researchers have increasingly questioned whether substantially lower doses might provide meaningful neurological benefits while minimizing many of the adverse effects associated with conventional psychiatric dosing. This concept has stimulated renewed scientific interest in low-dose lithium supplementation for depression, cognitive preservation, and healthy aging. How Low-Dose Lithium Supports Brain Health Unlike medications that target a single receptor, low-dose lithium affects numerous biological systems simultaneously. Several mechanisms appear particularly important. Increasing Brain-Derived Neurotrophic Factor (BDNF) BDNF functions as a biological fertilizer for the brain, promoting neuronal survival, dendritic branching, synapse formation, and learning. Patients with depression frequently demonstrate reduced circulating BDNF concentrations, while successful treatment often restores normal levels.¹¹ Low-dose Lithium consistently increases BDNF expression in both experimental and clinical studies, supporting the growth of healthier neuronal connections and improving the brain's ability to adapt following chronic stress. Inhibition of GSK-3β Among lithium's most extensively studied mechanisms is inhibition of glycogen synthase kinase-3 beta (GSK-3β). Overactivity of GSK-3β has been associated with: depression chronic inflammation impaired neuroplasticity tau phosphorylation Alzheimer's disease accelerated cognitive aging By partially inhibiting this enzyme, lithium appears to restore healthier intracellular signaling while reducing inflammatory injury within the brain.¹² Reducing Neuroinflammation Inflammation increasingly appears to contribute to depression in many patients. Elevated inflammatory cytokines—including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and C-reactive protein—have been associated with greater depressive symptom severity and poorer treatment response.¹³ Lithium modulates multiple inflammatory pathways, reducing microglial activation and limiting production of pro-inflammatory cytokines. This anti-inflammatory effect may partially explain its benefits extending beyond mood stabilization. Supporting Mitochondrial Function The brain consumes approximately 20% of the body's energy despite representing only about 2% of total body weight. Depression has increasingly been linked to impaired mitochondrial function, reduced ATP production, and increased oxidative stress.¹⁴ Experimental studies suggest lithium enhances mitochondrial efficiency, improves cellular energy production, and reduces oxidative damage. Healthier mitochondria translate into healthier neurons, potentially improving cognition, emotional resilience, and recovery from chronic stress. Neuroprotection and Healthy Aging One of the most exciting areas of current research is lithium's potential role in protecting the aging brain. Multiple observational studies have associated naturally occurring trace lithium in drinking water with lower rates of suicide, dementia, and all-cause mortality. Although these ecological observations cannot establish cause and effect, they have stimulated important research into lithium's potential as a neuroprotective intervention.¹⁵ Experimental investigations further suggest lithium reduces tau phosphorylation, decreases amyloid toxicity, preserves hippocampal neurons, and enhances neuronal survival following injury. Collectively, these findings have generated considerable interest in lithium as a possible contributor to healthy cognitive aging. Figure 1. How Low-Dose Lithium Supports Brain Health. Medical infographic illustrating the principal molecular mechanisms of microdose lithium, including GSK-3β inhibition, increased BDNF signaling, improved mitochondrial function, reduced neuroinflammation, enhanced autophagy, and their potential contributions to neuroprotection, cognitive resilience, and healthy aging. Professional medical infographic from Stages of Life Medical Institute. Lithium Carbonate vs. Low-Dose Lithium vs. Lithium Orotate Feature Conventional Lithium Carbonate Low-Dose Lithium Lithium Orotate* Primary Use Bipolar disorder Emerging adjunctive therapy Nutritional supplement formulation Typical Dose 600–1,800 mg/day Approximately 1–20 mg elemental lithium/day Usually supplied in low elemental doses Blood Monitoring Required Often individualized Determined by treating physician Evidence Base Extensive Growing Limited but increasing Suicide Prevention Strong evidence Unknown Unknown Neuroprotection Strong mechanistic evidence Promising Under investigation Prescription Required Yes Depends on formulation Generally available as a dietary supplement in the United States *Physician Perspective: In my clinical practice, I frequently prefer lithium orotate when considering low-dose lithium supplementation because it offers a practical means of delivering very small amounts of elemental lithium. However, direct comparative clinical trials between lithium orotate and prescription lithium carbonate remain limited. At present, the choice of formulation should be individualized, guided by the available evidence, clinical judgment, and careful patient monitoring rather than assumptions of superiority. What Your Doctor May Evaluate Before Recommending Lithium At Stages of Life Medical Institute, we believe depression should never be viewed as an isolated diagnosis. Instead, it is often the visible manifestation of multiple interacting physiological processes. Before recommending any treatment—including low-dose lithium—we perform a comprehensive evaluation designed to identify correctable contributors to mood disorders. A thorough assessment may include: Thyroid Function Hypothyroidism is one of the most frequently overlooked causes of fatigue, depression, impaired concentration, and reduced motivation. A comprehensive thyroid evaluation often includes TSH, Free T4, Free T3, Reverse T3, and thyroid antibody testing rather than TSH alone. Correction of thyroid dysfunction may significantly improve depressive symptoms in appropriately selected patients. Insulin Resistance The relationship between depression and metabolic dysfunction is increasingly recognized. Hyperinsulinemia, impaired glucose regulation, and chronic elevations in blood sugar contribute to systemic inflammation, oxidative stress, and reduced neuroplasticity. At our practice, fasting insulin and fasting glucose are routinely evaluated because metabolic health directly influences brain health. Nutritional Status Several nutritional deficiencies may contribute to depression, including: Vitamin D Vitamin B12 Folate Magnesium Omega-3 fatty acids Iron (when appropriate) Correcting deficiencies may enhance overall treatment response and improve energy, cognition, and mood. Inflammatory Markers Chronic inflammation has emerged as a major contributor to depression. Depending on the clinical situation, laboratory evaluation may include high-sensitivity C-reactive protein (hs-CRP), homocysteine, ferritin, or additional inflammatory biomarkers. Hormonal Balance Sex hormone deficiencies, adrenal dysfunction, and menopause or andropause may significantly influence mood, sleep quality, cognitive function, and emotional resilience. These factors should be considered when clinically appropriate. Sleep Quality Poor sleep contributes to impaired emotional regulation, increased inflammation, insulin resistance, and reduced BDNF production. Evaluation for insomnia, obstructive sleep apnea, circadian disruption, and poor sleep hygiene is an essential component of comprehensive depression management. Rather than searching for a single cause, we recognize that depression frequently reflects the cumulative effects of multiple biological stressors. Identifying and correcting these contributors often improves outcomes regardless of the specific therapy selected. Clinical Pearl The goal of treating depression should not simply be to suppress symptoms—it should be to restore healthy brain function. Successful treatment often requires improving sleep, reducing inflammation, correcting metabolic dysfunction, optimizing hormone balance, treating nutritional deficiencies, encouraging regular physical activity, and restoring healthy neuroplasticity. Medication, when indicated, should become one component of a broader strategy aimed at improving long-term brain health rather than simply reducing short-term symptoms. Physician Perspective One of the greatest advances in modern medicine has been recognizing that depression is a biological disorder involving far more than neurotransmitters alone. Throughout my years in clinical practice, I have found that many patients presenting with depression also exhibit insulin resistance, thyroid dysfunction, vitamin deficiencies, chronic inflammation, sleep disorders, or hormonal imbalance. Addressing these underlying abnormalities often enhances treatment response and improves overall health. Low Dose Lithium for Brain Health is one of these advances. When I consider low-dose lithium supplementation, I view it as part of this larger systems-based approach rather than a standalone solution. In selected patients, particularly those with persistent symptoms despite optimization of lifestyle and underlying medical conditions, carefully supervised low-dose lithium—often using lithium orotate—may represent an additional tool that supports neuroplasticity and healthy brain function. While emerging evidence is encouraging, treatment decisions should always be individualized and guided by current scientific evidence, careful clinical assessment, and appropriate monitoring. Frequently Asked Questions Is low-dose lithium the same treatment used for bipolar disorder? No. Conventional treatment for bipolar disorder uses substantially higher doses that require routine blood monitoring. Low-dose lithium typically provides much smaller amounts of elemental lithium and is being investigated for different clinical applications. Can lithium replace my antidepressant? No. Patients should never discontinue prescribed antidepressants without consulting their physician. Low-dose lithium may serve as an adjunctive therapy in carefully selected individuals, but it is not a substitute for appropriate medical care. Is lithium orotate safer than lithium carbonate? Lithium orotate generally contains much smaller amounts of elemental lithium than prescription lithium carbonate. However, limited comparative clinical trials prevent firm conclusions regarding relative safety or effectiveness. Physician supervision remains advisable whenever lithium supplementation is considered. Does lithium help prevent Alzheimer's disease? Current research is promising but not definitive. Experimental studies and some clinical investigations suggest lithium may reduce tau phosphorylation, improve neuroplasticity, and protect neurons. Additional large, well-controlled clinical trials are needed before lithium can be recommended specifically for dementia prevention. Should healthy individuals take lithium supplements? Routine supplementation cannot currently be recommended for the general population. Decisions regarding low-dose lithium should be individualized after consideration of medical history, current medications, kidney function, thyroid health, and overall clinical goals. What We Know • What We Think • What We Still Need to Learn What We Know What We Think What We Still Need to Learn Lithium reduces suicide risk in bipolar disorder and recurrent mood disorders. Low-dose lithium may improve mood by enhancing neuroplasticity and reducing neuroinflammation. Which patients benefit most from low-dose therapy? Lithium increases BDNF and inhibits GSK-3β. Neuroprotective effects may contribute to healthy cognitive aging. What is the optimal elemental lithium dose for depression? Depression involves inflammation, mitochondrial dysfunction, and impaired neuroplasticity. Carefully selected patients may benefit from lithium as part of a systems-based treatment plan. Long-term randomized trials comparing lithium orotate with lithium carbonate. Lithium influences multiple cellular signaling pathways. Earlier intervention may produce greater long-term neurological benefit. Long-term safety of chronic nutritional-dose lithium supplementation. Bottom Line Lithium has been one of psychiatry's most valuable medications for more than seven decades. Emerging research now suggests that substantially lower doses may offer benefits extending beyond traditional mood stabilization, including support of neuroplasticity, reduction of neuroinflammation, enhancement of mitochondrial function, and potential protection against age-related cognitive decline. Although these findings are encouraging, many important questions remain regarding optimal dosing, long-term safety, and patient selection. At Stages of Life Medical Institute, depression is approached as a disorder of whole-body physiology rather than neurotransmitters alone. Careful evaluation of thyroid function, metabolic health, nutritional status, inflammatory burden, hormonal balance, and sleep quality frequently identifies reversible contributors that deserve attention alongside any discussion of medication or supplementation. Low-dose lithium may become one component of a personalized treatment strategy—but it should always be considered within the broader context of restoring healthy brain function. Continue Your Journey to Better Health Depression rarely develops in isolation. Many of the biological pathways that influence mood also affect memory, metabolism, hormonal balance, inflammation, and healthy aginAdrenal Dysfunction and Adrenal Fatigue: Vital to Life, Yet Often Overlooked in Modern Medicineg. A systems-based understanding allows patients and clinicians to address these interconnected processes rather than focusing on symptoms alone. You may also enjoy these related articles from the Stages of Life Medical Institute blog: Vitamin D in Midlife May Reduce Tau Protein Accumulation Prediabetes: Is It a Real Disease? Why Can't My Doctor Find My Thyroid Problem? Hashimoto's Thyroiditis: Diagnosis and Treatment Lactoferrin, Colostrum, and Better Sleep Monocyte-to-Lymphocyte Ratio: An Emerging Marker for Brain Health Together, these topics illustrate how metabolic health, endocrine function, nutrition, inflammation, and sleep interact to influence mood, cognition, and longevity. Become a Patient If you are experiencing persistent depression, fatigue, cognitive decline, or simply wish to optimize your long-term brain health, Stages of Life Medical Institute provides comprehensive, physician-directed evaluations designed to identify the underlying biological contributors to your symptoms. Rather than treating isolated diagnoses, we emphasize personalized, evidence-based care that integrates modern medical science with a systems approach to prevention and healthy aging. To learn more about our comprehensive evaluations and services, visit: https://www.stagesoflifemedicalinstitute.com References Aron AR, et al. Lithium and neuroprotection: emerging mechanisms and clinical implications. Nature. 2025. Available at: https://www.nature.com/ Forlenza OV, et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomized controlled trial. Br J Psychiatry. 2011;198(5):351–356. PubMed: https://pubmed.ncbi.nlm.nih.gov/21525519/ Forlenza OV, et al. Long-term lithium treatment in older adults with amnestic mild cognitive impairment: extended follow-up study. Br J Psychiatry. 2019. PubMed: https://pubmed.ncbi.nlm.nih.gov/30947756/ Nunes MA, et al. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. Curr Alzheimer Res. 2013;10(1):104–107. PubMed: https://pubmed.ncbi.nlm.nih.gov/22746245/ Lu X, et al. Lithium and risk of dementia: systematic review and meta-analysis. Ageing Research Reviews. 2024. PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=lithium+dementia+meta-analysis+2024 Malhi GS, et al. Potential mechanisms of action of lithium in bipolar disorder. CNS Drugs. 2013;27(2):135–153. PubMed: https://pubmed.ncbi.nlm.nih.gov/23371914/ Chiu CT, et al. Neuroprotective mechanisms of lithium in neurological disorders. Trends Pharmacol Sci. 2013;34(10):589–595. PubMed: https://pubmed.ncbi.nlm.nih.gov/23948691/ Machado-Vieira R, et al. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects. Mol Psychiatry. 2009;14:197–207. PubMed: https://pubmed.ncbi.nlm.nih.gov/18268502/ Young W. Review of lithium effects on the brain and neurobiology. CNS Drugs. 2009. PubMed: https://pubmed.ncbi.nlm.nih.gov/19728706/ Gould TD, et al. Glycogen synthase kinase-3 inhibition by lithium. Pharmacology & Therapeutics. 2004. PubMed: https://pubmed.ncbi.nlm.nih.gov/15172765/ Beurel E, et al. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114–131. PubMed: https://pubmed.ncbi.nlm.nih.gov/25435019/ Matsunaga S, et al. Lithium as a treatment for Alzheimer's disease: systematic review and meta-analysis. J Alzheimers Dis. 2015. PubMed: https://pubmed.ncbi.nlm.nih.gov/26401736/ Nery FG, et al. Lithium and neurocognitive outcomes in bipolar disorder. Acta Psychiatr Scand. 2007. PubMed: https://pubmed.ncbi.nlm.nih.gov/17655563/ Cipriani A, et al. Lithium in the prevention of suicide in mood disorders: systematic review and meta-analysis. BMJ. 2013;346:f3646. PubMed: https://pubmed.ncbi.nlm.nih.gov/23814104/ Kessing LV, et al. Association between lithium treatment and reduced dementia risk. JAMA Psychiatry. 2017. PubMed: https://pubmed.ncbi.nlm.nih.gov/28445560/ McKnight RF, et al. Lithium toxicity profile: systematic review and meta-analysis. Lancet. 2012;379:721–728. PubMed: https://pubmed.ncbi.nlm.nih.gov/22265699/ Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4:27. PubMed: https://pubmed.ncbi.nlm.nih.gov/27535444/ Severus E, et al. The evidence for lithium in mood disorders. Int J Bipolar Disord. 2014;2:15. PubMed: https://pubmed.ncbi.nlm.nih.gov/25505622/ Malhi GS, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2021. PubMed: https://pubmed.ncbi.nlm.nih.gov/34187202/ National Institute for Health and Care Excellence. Bipolar disorder: assessment and management (NG222). Available at: https://www.nice.org.uk/guidance/ng222 Our Philosophy At Stages of Life Medical Institute, we believe symptoms rarely occur in isolation. Depression, fatigue, cognitive decline, metabolic dysfunction, hormonal imbalance, and chronic inflammation frequently represent interconnected biological processes rather than independent diseases. By identifying and treating the underlying contributors—not simply suppressing symptoms—we strive to improve healthspan, preserve cognitive vitality, and help our patients enjoy longer, healthier, and more fulfilling lives. The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Quercetin is a naturally occurring flavonoid being investigated for its potential role in supporting insulin sensitivity, glucose regulation, and metabolic health. Emerging research suggests it may influence some of the same glucose transport pathways targeted by prescription SGLT-2 inhibitors, while also providing antioxidant and anti-inflammatory benefits. Quick Look Quercetin is a naturally occurring plant compound found in onions, apples, berries, capers, and many other colorful foods. It is best known for its antioxidant and anti-inflammatory properties, but research suggests that certain forms of quercetin may also influence how the intestine and kidneys handle glucose. This has led some researchers to ask whether quercetin might produce a mild version of certain effects associated with prescription sodium-glucose cotransporter-2, or SGLT-2, inhibitors. These medications lower blood sugar, promote modest weight loss, and protect the heart and kidneys. Emerging observational research also raises the possibility that they could reduce the occurrence of certain cancers, although this has not been proved. Quercetin is not equivalent to an SGLT-2 medication and should not be used as a substitute for prescribed diabetes treatment. Nevertheless, its effects on glucose regulation, inflammation, blood vessels, and insulin sensitivity make it an intriguing component of a broader metabolic-health strategy. Quercetin 500 mg 50 Tablets A Plant Compound With Broad Biological Activity Quercetin belongs to a large family of plant nutrients known as flavonoids. Plants produce flavonoids partly to protect themselves from ultraviolet radiation, infection, oxidation, and environmental stress. When consumed by humans, some of these compounds appear to influence protective cellular pathways. Quercetin has been studied for possible effects on: insulin sensitivity inflammation oxidative stress blood pressure blood-vessel function mitochondrial health immune regulation Human trials suggest that quercetin supplementation may modestly reduce insulin levels and systolic blood pressure in some populations, although effects on fasting glucose, hemoglobin A1c, cholesterol, and body weight have been inconsistent.¹⁻³ This is an important distinction. Quercetin has promising biological activity, but many of its proposed benefits remain more convincing in laboratory and animal studies than in large human clinical trials. Understanding the SGLT System Figure 1. How SGLT-2 inhibition changes glucose handling. Under normal conditions, the kidneys reclaim nearly 90% of filtered glucose through the SGLT-2 transporter in the proximal tubule. Blocking this transporter allows excess glucose to be excreted in the urine, lowering blood sugar while providing cardiovascular and kidney protection. Quercetin is being investigated for its potential influence on related glucose transport pathways, although it is not a replacement for prescription SGLT-2 inhibitors. The kidneys continuously filter the blood. Glucose passes into this filtered fluid, but under normal circumstances, nearly all of it is returned to the bloodstream rather than lost in the urine. This glucose recovery is accomplished primarily by proteins called sodium-glucose cotransporters. SGLT-2 is located mainly in the first portion of the kidney tubule and is responsible for reclaiming most of the glucose filtered by the kidneys. SGLT-1 completes much of the remaining glucose reabsorption and also helps absorb glucose from the intestine. When SGLT-2 is inhibited: less glucose returns to the bloodstream more glucose leaves the body in the urine blood glucose decreases some calories are lost insulin requirements may decline blood pressure may fall slightly pressure within the kidney’s filtering system improves This mechanism led to the development of prescription medications including empagliflozin, dapagliflozin, canagliflozin, and ertugliflozin. Prescription SGLT-2 Inhibitors and Diabetes Care SGLT-2 inhibitors were originally developed to lower blood glucose in people with type 2 diabetes. Their mechanism seemed straightforward: allow some of the filtered glucose to leave through the urine rather than returning it to the bloodstream. What followed was unexpected. Large clinical trials demonstrated that the benefits of these medications extend well beyond hemoglobin A1c. SGLT-2 inhibitors consistently reduce hospitalization for heart failure and slow the progression of chronic kidney disease. These benefits can occur even when their effect on blood glucose is relatively modest.⁴⁻⁶ The medications are now used not only in diabetes but also in many patients with heart failure or chronic kidney disease who do not have diabetes. Their evolution illustrates an important principle: improving metabolic health involves much more than lowering a laboratory glucose value. SGLT-2 Inhibitors and Weight Loss Each gram of glucose lost through the urine carries calories with it. Over time, this produces a modest caloric deficit. Most patients lose a relatively small amount of weight rather than experiencing the dramatic weight reduction sometimes seen with GLP-1 medications. Across clinical trials, the average reduction is commonly in the range of several pounds. The response varies according to the medication, dose, kidney function, diet, baseline weight, and duration of treatment.⁷⁻⁹ The weight loss appears to come primarily from fat mass, although some studies have also raised concern about small reductions in lean tissue, particularly in older adults. For that reason, adequate dietary protein and resistance exercise remain important when these medications are used in aging patients. SGLT-2 inhibitors should therefore not be considered primary weight-loss medications. Their value lies in the combination of modest weight reduction with improved glucose regulation, lower blood pressure, and meaningful heart and kidney protection. Reducing Glucotoxicity and Insulin Demand Persistently elevated glucose can impair the function of insulin-producing pancreatic beta cells and worsen insulin resistance. This process is sometimes called glucotoxicity. By removing glucose through the urine, SGLT-2 inhibitors reduce the amount of glucose that must be handled by insulin. This does not directly reverse every cause of insulin resistance, but it can reduce the metabolic burden created by chronic hyperglycemia. In practical terms, the body does not have to produce as much insulin to manage the same glucose load. This may be particularly helpful when diabetes is accompanied by obesity, fatty liver disease, hypertension, or chronic kidney disease. Heart and Kidney Protection SGLT-2 inhibitors reduce pressure inside the kidney’s filtering units and can slow the decline of kidney function. They also promote mild sodium and fluid loss, improve cardiac energy use, and reduce the likelihood of fluid overload. Across major clinical trials and meta-analyses, the most consistent benefits have been: fewer hospitalizations for heart failure slower progression of chronic kidney disease fewer serious kidney outcomes reduced cardiovascular risk in selected high-risk patients These protective effects are now considered central features of the drug class rather than secondary benefits.⁴⁻⁶ Could SGLT-2 Inhibitors Reduce Cancer Prevalence? Diabetes, obesity, hyperinsulinemia, and chronic inflammation are associated with increased risk for several forms of cancer. It is therefore reasonable to ask whether improving these metabolic disturbances might also affect cancer risk. Recent observational studies and meta-analyses have reported lower overall cancer rates among some patients using SGLT-2 inhibitors compared with patients using certain other diabetes medications. Possible reductions have been reported for liver, lung, prostate, gastrointestinal, and other cancers.¹⁰⁻¹² These findings are intriguing, but they must be interpreted cautiously. The available evidence is not fully consistent. Some analyses show a lower incidence of selected cancers, others find an overall neutral effect, and a few have raised questions about individual cancer categories. Much of the apparent benefit comes from observational data rather than randomized trials designed specifically to study cancer prevention.¹⁰⁻¹³ Patients prescribed SGLT-2 inhibitors may also differ from comparison groups in weight, kidney function, smoking history, medication use, access to health care, and other factors that influence cancer risk. At present, SGLT-2 inhibitors should not be prescribed as cancer-prevention drugs. The most accurate conclusion is that they do not appear to increase overall cancer risk, and emerging evidence suggests they might reduce the occurrence of some cancers. Whether this represents a direct anticancer effect or an indirect benefit of improved metabolic health remains unsettled. Can Quercetin Do Something Similar? This is where the discussion becomes both interesting and easily overstated. Certain quercetin compounds—particularly quercetin glucosides—interact with sodium-glucose transporters in laboratory studies. The strongest direct evidence involves intestinal SGLT-1, where quercetin glucosides can compete with glucose transport and reduce glucose uptake.¹⁴⁻¹⁶ The evidence that ordinary supplemental quercetin meaningfully inhibits kidney SGLT-2 in humans is much less developed. Some laboratory and computer-modeling studies suggest possible interaction with glucose transport pathways, but this has not been established as a clinically important renal effect. Quercetin should therefore not be described simply as a natural equivalent of empagliflozin or dapagliflozin. A more accurate interpretation is that quercetin may influence glucose handling through several pathways, potentially including intestinal glucose absorption, insulin signaling, inflammation, oxidative stress, and cellular glucose transport. Any direct SGLT-2 effect in humans remains investigational. Clinical Pearl One of the advantages of many nutritional compounds is also one of the reasons they are difficult to study: they may influence several pathways at once. Quercetin does not appear to act as a powerful, single-target medication. Instead, it may modestly affect glucose absorption while also influencing inflammation, oxidative stress, vascular function, mitochondrial activity, and insulin signaling. This broader activity may complement a comprehensive metabolic program, but it also means that quercetin’s effects cannot be assumed to match those of a prescription SGLT-2 inhibitor. Quercetin and Insulin Resistance Figure 2. Prescription SGLT-2 inhibitors versus quercetin. Prescription SGLT-2 inhibitors have proven benefits for lowering blood glucose, promoting modest weight loss, protecting the heart and kidneys, and reducing cardiovascular events. Quercetin is a naturally occurring flavonoid with antioxidant, anti-inflammatory, and metabolic properties that may influence glucose transport pathways, but current evidence supports its use as a complementary nutritional strategy rather than a substitute for prescription therapy. Insulin resistance develops when muscle, liver, fat, and other tissues become less responsive to insulin. The pancreas compensates by producing more insulin. Blood sugar may remain within the conventional laboratory range for years while insulin levels steadily rise. Eventually, the pancreas may no longer produce enough insulin to overcome the resistance. Glucose then rises into the ranges labeled prediabetes and type 2 diabetes. Quercetin may support insulin sensitivity by: reducing oxidative stress that interferes with insulin signaling decreasing inflammatory signaling influencing enzymes involved in glucose metabolism supporting endothelial and mitochondrial function possibly reducing intestinal glucose absorption in certain forms Clinical evidence remains mixed. A meta-analysis of randomized trials found that quercetin may reduce fasting glucose under certain conditions, particularly with doses of at least 500 milligrams daily and treatment lasting eight weeks or longer. A later analysis found a reduction in insulin but not consistent improvements across all cardiometabolic measures.¹,² The most defensible conclusion is that quercetin may provide modest metabolic support, but it is not a reliably proven treatment for diabetes or insulin resistance by itself. Could Quercetin Assist With Weight Management? Quercetin has been associated with changes in fat metabolism, inflammation, and mitochondrial function in laboratory research. Animal studies have also suggested possible effects on fat accumulation and energy regulation. Human evidence for meaningful weight loss, however, is limited and inconsistent. Quercetin does not cause urinary calorie loss comparable to prescription SGLT-2 inhibitors, and it should not be presented as a stand-alone weight-loss supplement. Any benefit is more likely to be indirect—for example, through improved metabolic flexibility, reduced inflammation, or better support of insulin signaling. Weight reduction still depends primarily on nutrition, physical activity, muscle preservation, sleep, hormonal health, and correction of the underlying factors driving insulin resistance. Quercetin, Inflammation, and Cancer Biology Quercetin has demonstrated anticancer activity in cell and animal models. It has been studied for its effects on oxidative stress, inflammatory signaling, cell-cycle regulation, apoptosis, and pathways involved in tumor growth.³ However, laboratory anticancer activity does not prove that taking quercetin supplements reduces cancer prevalence in humans. There is currently insufficient clinical evidence to recommend quercetin as a cancer-prevention or cancer-treatment agent. Patients undergoing cancer treatment should also discuss supplementation with their oncology team because antioxidants and plant compounds may interact with chemotherapy, radiation, anticoagulants, or other medications. Its most reasonable role is as one component of a plant-rich dietary pattern that supports overall metabolic health—not as a replacement for cancer screening, medical evaluation, or established treatment. Beyond Blood Sugar Figure 3. Quercetin's potential benefits for metabolic health and insulin resistance. Quercetin is a naturally occurring flavonoid that may support insulin sensitivity, glucose metabolism, endothelial function, mitochondrial health, and the body's antioxidant and anti-inflammatory defenses. Rather than acting through a single mechanism, quercetin appears to influence multiple interconnected biological pathways involved in cardiometabolic health and healthy aging. Although promising, it should be considered a complementary nutritional strategy rather than a replacement for evidence-based medical therapy. Quercetin’s potential value may extend beyond its effect on glucose. Inflammation Quercetin can influence inflammatory signaling pathways, including NF-κB and several inflammatory cytokines. Most dramatic findings come from preclinical research, while human responses tend to be smaller and more variable.³ Blood-Vessel Function Oxidative stress can reduce nitric oxide availability and impair normal blood-vessel relaxation. Quercetin may support endothelial function and has produced modest reductions in blood pressure in some clinical studies.²,³ Oxidative Stress Quercetin can interact directly with reactive oxygen species and may also influence the body’s own antioxidant-defense systems. Mitochondrial Health Preclinical evidence suggests that quercetin may support mitochondrial signaling and energy metabolism. Whether this produces clinically meaningful improvements in longevity remains unknown. These diverse actions are biologically interesting, but they should be viewed as supportive mechanisms rather than proof that quercetin prevents specific diseases. Food Sources of Quercetin Quercetin is naturally present in: capers red and yellow onions apples, especially the peel berries cherries kale broccoli asparagus tea grapes Capers and onions are among the richest commonly consumed sources. The amount absorbed varies according to the food, its preparation, the form of quercetin present, intestinal function, and the gut microbiome. A colorful, plant-rich diet provides quercetin together with fiber, minerals, vitamins, and many other phytonutrients that may work collectively. Should You Take a Quercetin Supplement? Supplemental doses used in human studies commonly range from approximately 500 to 1,000 milligrams daily, although there is no universally accepted dose for treating insulin resistance or diabetes. Quercetin is absorbed imperfectly, and formulations vary substantially. Some products combine it with vitamin C, bromelain, phospholipids, or specialized delivery systems intended to improve absorption. More absorption is not automatically better. A highly bioavailable formulation may produce different effects and interactions than traditional quercetin preparations. Patients should discuss supplementation with a knowledgeable clinician, especially when taking: anticoagulants or antiplatelet medications diabetes medications blood-pressure medications immunosuppressive drugs chemotherapy multiple prescription medications Quercetin should not be used to replace metformin, an SGLT-2 inhibitor, a GLP-1 medication, insulin, or another prescribed therapy. Safety Quercetin is generally well tolerated in short-term human studies. Reported adverse effects may include: stomach discomfort nausea headache tingling sensations Long-term safety data at high supplemental doses remain less complete. Caution is appropriate in patients with significant kidney disease, during pregnancy, and when quercetin is combined with medications that have narrow therapeutic ranges. Patients taking both quercetin and prescription glucose-lowering therapy should monitor glucose appropriately. Although quercetin alone is unlikely to produce the glucose-lowering potency of an SGLT-2 medication, combinations can sometimes behave differently than expected. What We Still Do Not Know Important unanswered questions include: whether supplemental quercetin meaningfully inhibits renal SGLT-2 in humans which quercetin forms best influence intestinal glucose absorption whether it produces durable improvements in hemoglobin A1c whether it meaningfully assists with weight loss whether it reduces diabetes complications whether it adds benefit to prescription SGLT-2 therapy which formulations and doses provide the best balance of absorption and safety whether its preclinical anticancer effects translate into reduced cancer incidence in humans These questions require larger, longer, well-controlled clinical trials. Bottom Line Quercetin is a biologically active plant compound with potentially useful effects on inflammation, oxidative stress, vascular function, insulin signaling, and glucose handling. Certain quercetin glucosides can interact with intestinal SGLT-1, and emerging laboratory research has raised interest in other glucose-transport pathways. However, quercetin has not been shown to reproduce the renal SGLT-2 inhibition or the proven heart and kidney outcomes associated with prescription SGLT-2 medications. Prescription SGLT-2 inhibitors can lower blood glucose, promote modest weight loss, reduce heart-failure hospitalization, and slow kidney disease. Emerging research also suggests a possible reduction in certain cancers, but this remains unproven and should not yet be considered an established benefit. Quercetin may serve as a useful nutritional adjunct within a comprehensive plan for insulin resistance and metabolic health. It should not be regarded as a natural replacement for diabetes medication, medical weight-loss treatment, cancer screening, or individualized medical care. Continue Your Journey to Better Health Metabolic dysfunction rarely involves blood sugar alone. Insulin resistance interacts with inflammation, mitochondrial function, liver health, vascular health, body composition, sleep, nutrition, and hormonal regulation. Exploring these interconnected systems can help identify metabolic changes long before diabetes and its complications become firmly established. Continue your journey with these related articles from Stages of Life Medical Institute: Pre-Diabetes: Is It a Real Thing? Alpha-Lipoic Acid: Antioxidant Support for Metabolic Health Berberine and Blood-Sugar Regulation C15:0 Essential Fatty Acid and Healthy Aging Optimal Uric Acid Levels for Longevity Magnesium Deficiency, Insulin Resistance, and Cardiovascular Health Become a Patient At Stages of Life Medical Institute, we evaluate metabolic health using more than fasting glucose alone. Depending on the individual, assessment may include hemoglobin A1c, fasting insulin, lipid patterns, liver markers, kidney function, inflammation, hormone balance, body composition, and other indicators of metabolic stress. Our goal is to identify insulin resistance early and create an individualized plan incorporating nutrition, movement, sleep, appropriate supplementation, and prescription treatment when medically indicated. At Stages of Life Medical Institute, we believe symptoms rarely occur in isolation. Instead, they reflect complex interactions among genetics, nutrition, hormones, metabolism, inflammation, environmental exposures, and lifestyle. Our systems-based approach seeks to identify and address these root causes, helping patients achieve lasting health rather than simply treating individual symptoms. References Ostadmohammadi V, Milajerdi A, Ayati E, et al. Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(5):1330–1340. PubMed Arabi SM, Bahrami LS, Rahnama I, Sahebkar A. The effects of quercetin supplementation on cardiometabolic parameters: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2023. PubMed Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin. Pharmaceuticals. 2023;16(7):1020. PubMed Central McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021;6(2):148–158. PubMed Toyama T, Neuen BL, Jun M, et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis. Diabetes Obes Metab. 2019;21(5):1237–1250. PubMed Lo KB, Gul F, Ram P, et al. The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: a systematic review and meta-analysis. Cardiorenal Med. 2020;10(1):1–10. PubMed Cai X, Yang W, Gao X, et al. The association between the dosage of SGLT2 inhibitor and weight reduction in type 2 diabetes patients: a meta-analysis. Obesity. 2018;26(1):70–80. PubMed Wang H, Yang J, Chen X, Qiu F. Effects of sodium-glucose cotransporter 2 inhibitor monotherapy on weight changes in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis. Clin Ther. 2019;41(2):322–334.e11. PubMed Cho YK, Kim YJ, Jung CH. Effect of sodium-glucose cotransporter 2 inhibitors on weight reduction in overweight and obese populations without diabetes: a systematic review and meta-analysis. J Obes Metab Syndr. 2021;30(4):336–344. PubMed Hajishah H, et al. Comparative risk of cancer associated with SGLT inhibitors versus DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis. 2025. PubMed Xu B, et al. Association between sodium-glucose cotransporter-2 inhibitors and cancer risk in patients with type 2 diabetes mellitus. 2025. PubMed Wang Y, et al. Impact of SGLT2 inhibitors on tumor development risk in patients with type 2 diabetes mellitus. 2025. PubMed Central Spiazzi BF, et al. Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2023. PubMed Ader P, Blöck M, Pietzsch S, Wolffram S. Interaction of quercetin glucosides with the intestinal sodium/glucose cotransporter. Cancer Lett. 2001;162(2):175–180. PubMed Wolffram S, Blöck M, Ader P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush-border membrane of rat small intestine. J Nutr. 2002;132(4):630–635. PubMed Cermak R, Landgraf S, Wolffram S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br J Nutr. 2004;91(6):849–855. PubMed The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com

Adrenal Dysfunction and Adrenal Fatigue: Understanding the vital role adrenal glands play in regulating stress response, inflammation, metabolism, hormone balance, and long-term health. Quick Look The adrenal glands are small but essential organs responsible for producing hormones that regulate stress response, blood pressure, metabolism, inflammation, immune balance, electrolyte control, and survival itself. While severe adrenal failure such as Addison’s Disease often receives medical attention, milder forms of adrenal dysfunction frequently remain undetected for years. Chronic stress, poor sleep disruption, nutritional deficiency, inflammation, and medication exposure may gradually impair adrenal reserve long before overt disease develops.¹ The Most Important Glands You Rarely Hear About Hidden quietly above each kidney sit two small triangular organs weighing only a few grams each — the adrenal glands. Despite their small size, these structures regulate numerous essential physiologic processes including blood pressure regulation, glucose metabolism, electrolyte balance, inflammatory control, immune regulation, stress adaptation, and circadian rhythm maintenance.² Without functioning adrenal glands, survival becomes impossible. Figure 1. The adrenal glands sit atop the kidneys and regulate critical physiologic functions including stress response, cortisol production, blood pressure control, immune regulation, metabolism, and hormone balance essential for survival. Understanding the Anatomy of the Adrenal Cortex The adrenal cortex consists of three specialized zones responsible for producing steroid hormones critical to life. Zona Glomerulosa The outer cortical layer synthesizes aldosterone, a mineralocorticoid that regulates sodium retention, potassium excretion, fluid balance, and long-term blood pressure regulation.³ Deficiency may contribute to: Orthostatic dizziness Salt craving Low blood pressure Dehydration Cardiac rhythm instability Zona Fasciculata This middle layer produces cortisol, the body’s principal glucocorticoid. Cortisol regulates: Blood sugar stability Immune modulation Inflammatory suppression Stress adaptation Cognitive function Circadian rhythm Under normal physiologic conditions, humans produce approximately 35–40 mg cortisone equivalent daily, with production increasing substantially during infection, illness, trauma, or physiologic stress.⁴ Zona Reticularis This inner cortical zone produces androgen precursors including: DHEA DHEA-Sulfate Testosterone precursors These hormones influence: Libido Mood stability Muscle preservation Cognitive health Immune regulation ⁵ Figure 2. The adrenal cortex contains three specialized zones that produce essential hormones including aldosterone, cortisol, DHEA, and catecholamines, regulating blood pressure, metabolism, stress adaptation, immune balance, inflammation, and hormone production. The HPA Axis and the Reality Behind Adrenal Fatigue The term adrenal fatigue remains controversial in traditional endocrinology. Technically, the adrenal glands themselves rarely become structurally exhausted. However, the physiologic process is very real. Adrenal ENH Bottle #120 Adrenal ENH bottle #120 More accurately, dysfunction occurs within the Hypothalamic-Pituitary-Adrenal Axis (HPA Axis) — the integrated communication network connecting: Brain Hypothalamus Pituitary gland Adrenal glands Sympathetic nervous system Immune system When chronic stress persists, cortisol secretion patterns become abnormal and the body gradually loses physiologic adaptability.⁶ Common symptoms include: Morning fatigue Brain fog Insomnia Afternoon energy crashes Anxiety Reduced exercise recovery Depression Poor concentration Increased inflammatory symptoms The Important Relationship Between Adrenal Dysfunction and Hypothyroidism One frequently overlooked clinical relationship involves the close physiologic connection between adrenal function and the thyroid gland. The thyroid regulates metabolic rate, while the adrenal glands help the body tolerate the metabolic demands created by thyroid hormone itself. In patients with chronic adrenal insufficiency or subtle HPA axis dysfunction, symptoms of hypothyroidism often become more pronounced, including fatigue, weight gain, depression, cold intolerance, and cognitive slowing. In autoimmune disorders, this relationship becomes even more significant, as conditions such as Hashimoto's Thyroiditis and Addison's Disease may occur together as part of a broader autoimmune endocrine syndrome. Clinically, initiating thyroid hormone replacement in a patient with unrecognized adrenal insufficiency may worsen symptoms by increasing metabolic demand faster than the adrenal glands can compensate. For this reason, careful evaluation of both systems is often necessary when patients present with persistent fatigue, hormonal imbalance, and unexplained failure to improve despite standard thyroid treatment. Clinical Pearl Patients frequently present with chronic unexplained fatigue while standard laboratory testing appears entirely normal. CBC normal. Chemistry panel normal. Thyroid studies normal. Cardiac evaluation normal. Yet the patient continues to decline. In many cases, the missing diagnosis involves dysfunction of the body’s stress adaptation systems rather than frank endocrine failure. Functional medicine attempts to recognize physiologic dysfunction long before irreversible organ failure develops.⁷ Addison’s Disease: Severe Adrenal Failure Addison's Disease represents the extreme end of adrenal dysfunction. The adrenal gland loses the ability to produce adequate corticosteroid hormones. Common causes include: Autoimmune destruction of adrenal tissue 21-Hydroxylase antibodies Chronic narcotic exposure Infection Adrenal hemorrhage Neoplasm Severe chronic stress Trauma Symptoms often develop slowly over months or years.⁸ Typical manifestations include: Severe fatigue Muscle weakness Weight loss Low blood pressure Nausea Vomiting Depression Salt craving Dizziness Chronic dehydration Subclinical forms may remain undiagnosed for prolonged periods. Modern Causes of Adrenal Dysfunction Numerous modern lifestyle factors may gradually impair adrenal regulation. Common contributors include: Chronic sleep deprivation⁹ Persistent psychological stress¹⁰ Inflammatory disorders Insulin resistance Blood sugar instability Chronic opioid use Nutritional deficiency Excessive caffeine dependence Chronic sympathetic nervous system activation Figure 3. Chronic stress, poor sleep, inflammation, nutritional deficiencies, and metabolic dysfunction can disrupt the hypothalamic-pituitary-adrenal (HPA) axis, leading to adrenal dysfunction, fatigue, cortisol imbalance, poor recovery, and widespread physiologic decline. The Bottom Line The adrenal glands regulate survival itself. They control inflammation, metabolism, immune regulation, blood pressure stability, stress adaptation, and energy production. Severe adrenal failure such as Addison’s Disease is uncommon. Milder forms of adrenal dysfunction are far more common and frequently overlooked. Persistent fatigue, insomnia, poor stress tolerance, mood disturbance, inflammation, and poor physiologic recovery should never simply be dismissed as aging. Sometimes the body is not lacking motivation. Sometimes the body has simply lost its ability to adapt. References 1. Nieman LK. Physiology of the adrenal gland and adrenal disorders. New England Journal of Medicine.PubMed Reference 1 2. Hall JE. Endocrine physiology and adrenal regulation. Guyton and Hall Textbook of Medical Physiology.Reference Source 2 3. Hattangady NG, Olala LO, Bollag WB, Rainey WE. Regulation of aldosterone production. Molecular and Cellular Endocrinology.PubMed Reference 3 4. Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP. Stress physiology and cortisol regulation. Endocrine Reviews.PubMed Reference 4 5. Labrie F. DHEA and adrenal androgen physiology. Journal of Endocrinology.PubMed Reference 5 6. Chrousos GP. Stress and disorders of the stress system. Nature Reviews Endocrinology.PubMed Reference 6 7. McEwen BS. Protective and damaging effects of stress mediators. Physiological Reviews.PubMed Reference 7 8. Betterle C, Morlin L. Autoimmune Addison disease. Autoimmunity Reviews.PubMed Reference 8 9. Meerlo P, Sgoifo A, Suchecki D. Restricted sleep and endocrine dysfunction. Sleep Medicine Reviews.PubMed Reference 9 10. Sapolsky RM. Stress physiology and allostatic load. Physiology & Behavior.Reference Source 10 The medical references cited in this article are provided for educational purposes only and are intended to support general scientific discussion. They are not a substitute for individualized medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional who can account for a patient’s unique medical history, medications, and circumstances. Subscribe to our Blog Highest Quality, GMP Manufactured Products 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com